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The Feasibility of Using Brief Cognitive Behavioural Therapy for 
Depression Associated with Parkinson's disease 
People with depression in Parkinson's disease are rarely offered therapeutic assistance. 
This study set out to investigate the efficacy of an eight-session structured cognitive 
behavioural. intervention in reducing symptoms of depression. Five depressed patients 
(age range 54 to 82) attending a North Wales movement disorder clinic agreed to 
participate. Outcome was assessed using mood and quality of life inventories (Beck 
Depression Inventory; Geriatric Depression Scale; Parkinson's Disease Quality of Life 
Questionnaire). Four individuals demonstrated a clinically reliable reduction of 
symptoms according to the GDS scores, with greater improvement reported for the two 
individuals with more severe pre-therapy levels of depression. The BDI findings 
suggested most of the improvement related to the cognitive dimensions of guilt, 
pessimism and failure. The change in mood was not generally accompanied by an 
enhancement of perceived quality of life, and little variation in the frequency of activities 
was reported over the course of therapy. The difficulty in challenging rational cognitions 
and organic factors are highlighted as key issues in the psychological treatment of 
depression for this population. 
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RESEARCH PROTOCOL 
The Effectiveness of Brief Collnitive Behaviour Therapv in Reducinz the Symptoms 
of Depression in Individuals with Parkinson's disease. 
The potential value of addressing this issue 
At the present time patients with depression in Parkinson's disease (PD) are not 
routinely offered psychological therapy in the form of cognitive behaviour therapy 
(CBT). Evidence that CBT can reduce depressive symptoms would highlight a treatment 
option for individuals coping with this chronic condition. 
Introduction 
Depression is the most common neuropsychiatric complaint in PD (Aarsland et 
al., 1999). Although prevalence estimates vary in accord with the measures used, one 
local community based study identified depression in 64% of PD patients (Meara, 
Michelmore, & Hobson, 1999). Studies indicate that depression in PD is often not treated 
(Cummings & Masterman, 1999). Even when pharmacological approaches have been 
used they do not seem to be effective for all patients (Cummings, 1992). Untreated 
depression is likely to lead to poor outcome for the patients in terms of increased 
disability, morbidity and mortality (Cummings & Masterman, 1999). 
Opinions differ regarding the factors thought to contribute to depression in PD. 
One approach maintains that affective symptoms are linked to the neuropathology of PD 
(Tandberg, et al., 1996; Mayberg & Solomon, 1995). Another view argues *that 
depression represents a reaction to the changes in lifestyle imposed by physical 
impairments (Sharag, Jahanshahi, & Quinn, 2001). The question of whether depression 
in PD is biologically or socially mediated should not preclude attempts to try non- 
pharmacological treatment strategies. 
Cognitive behaviour therapy is a structured, problem orientated approach, which 
encourages collaboration between therapist and patient. CBT is based on a theory 
expounded by Aaron T Beck which proposes that during depression people tend to 
perceive events in an overly negative or distorted manner (Beck, 1995). These appraisals 
are thought to determine how the individual feels and behaves. 
I 
The process of CBT, which commonly includes evaluating alternative solutions to 
problems and identifying patterns of helpful rather than depressive thinking, suggests that 
the approach is ideally suited to treating depression linked to medical conditions 
(Laidlaw, 2001). Literature shows that CBT has been used to facilitate adjustment to a 
range of health related concerns including pain, chronic fatigue and palliative care 
(White, 2001; Keelfe, Jacobs & Siddle, 1997; Edelman & Kidman, 1999). Watt & 
Cappeluz (2000) demonstrated that brief CBT was able to reduce symptoms of 
depression in patients in the early stages of organic illness. However the efficacy of CBT 
in treating depression in PD has not been established. 
Objectives of the sLudy. 
The primary aim of the study is to ascertain whether brief cognitive behaviour 
therapy can reduce symptoms of depression in patients with PD. Secondly, the study 
aims to evaluate whether improvement can be maintained a month following cessation of 
therapy. The hypothesis predicts that there will be a decline in symptoms of depression 
following brief CBT. The decline will be represented by lower scores on the Beck 
Depression Inventory and Geriatric Depression Scale in the post therapy and follow up 
assessments compared to pre treatment scores. The hypothesis predicts that there will be 
an improvement in the quality of life as measured by the Parkinson's Disease Quality of 
Life Questionnaire which will be represented as higher scores on items post treatment. 
DesiRn 
A feasibility study using a repeated measures design will be employed. A sample 
of up to twenty participants will be asked to complete the Beck Depression Inventory 
(BDI), the Geriatric Depression Scale (GDS) and the Parkinson's Disease Quality of Life 
Questionnaire (PDQL) on three occasions, a) pre-therapy, or before the start of the 
therapy program, b) post-therapy, or after the final therapy session, and, c) follow up, or 
one month after therapy has finished. Participants may be asked to provide information 
on a small range of clinically relevant symptoms before during and after the therapeutic 
intervention (e. g. how low they have been feeling today). 
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Participants. 
Males and females with scores of 5 of more on the GDS, who are currently 
attending the Parkinson's disease Clinic based at Ysbyty Glan Clwyd will be approached 
by letter. All patients will have reýeived a diagnosis according to the UK Brain Bank 
criteria for probable Parkinson's disease. Physical disability levels will vary. Disability 
will have been assessed by a medical practitioner using the Unified Parkinson's Disease 
Rating Scale (UPDRS). Some patients may be taking medication for symptoms of 
Parkinson's disease or depression. Participants who are receiving drug treatment will not 
be excluded from the trial. 
Measures. 
The Geriatric Depression Scale (GDS-15, Yesavage et al., 1983). The GDS-15 is 
a short inventory designed to measure symptoms of depression commonly observed in 
the older adult population. Research comparing the GDS with clinical diagnoses has 
established the inventory as a reliable measure of depression in older adults (Lam & W. 
Power, 1991). As the Parkinson's disease iHinic use the GDS as a routine screening 
measure, the use of the same inventory would provide clinicians with a recognizable 
gauge to evaluate the effectiveness of psychological treatment. 
The Beek Depression Inventory (BDI-11, Beck & Steer, 1993). The BDI is a 21 
item validated self-report inventory measuring symptoms commonly associated with 
depression. The BDI is a key research tool used to measure outcomes following CBT in 
late life depression and chronic illness (Laidlaw, 2001). The inclusion of the scale in this 
study would enable the investigator to examine whether outcomes for CBT in PD 
compare with outcomes for other chronic illness groups. 
Parkinson's Disease Quality of Life Questionnaire (PDOL; obson, Holden & 
Meara, 1999). The PDQL is a 37 item self administered questionnaire containing four 
subscales: Parkinson symptoms, systemic symptoms, social functioning and emotional 
functioning. Hobson, Holden and Meara (1999) found the anglicized version of the 
PDQL was a useful disease-specific measure with good convergent and discriminative 
validity. 
Method 
'Prospective participants will be sent. an approach letter explaining the reason for 
contact. During a pre research home visit the investigator will outline the aims of the 
study with the aid of a patient information sheet. The issue of consent will be explained 
and a second home based appointment will be arranged. No financial reward will be 
made for participation. The GP will be informed of their patient's participation in the 
proj ect. 
Content and structure of the CBT intervention 
Subject to consent, the individual intervention will begin. The program will 
comprise of eight therapy sessions of approximatqly one-hour duration. The content of 
program will be based on the core principles of Cognitive Behaviour Therapy (CBT) as 
expounded by Beck (1976). The patient will"be provided with the booklet 'Coping with 
Depression When you Have Parkinson's Disease'. (Beck, 2000). This short simple 
booklet describes the main components of cognitive therapy in the context of Parkinson's 
disease. The structure of the sessions will be guided by the following headings outlined 
in the booklet; 
How should I change my behaviour 
How should I change my depressive thinking 
How do I solve my problems 
How can I help myself follow my doctor's advice? 
The initial session will aim to build a rapport with the participant by providing the 
opportunity to talk through salient concerns. The plan for subsequent sessions will be 
discussed. The first two therapy sessions will focus on changing behaviour by 
encouraging the introduction of appropriate activities. The following two sessions will 
look at the process of changing depressive thinking. The next session will look at 4D 
problem solving various situations pertinent for the individual. The final session will 
review what has been done and consider the future expectations and strategies for coping 
with depression in Parkinson's disease. A follow up session will be provided one month 
after the termination of therapy. Following data analysis, the investigator will forward a 
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short report providing general feedback for the group outcome to each participant. No 
information on individual participants will be made available. 
Data analysis 
The outcome data will be checked and scored by a research assistant. The data 
analysis will be computed using SPSS. Standardised statistical techniques will be used, 
which, depending on sample size, will include non parametric tests for repeated measures 
(e. g. Freidmans and Wilcoxon). Information on clinical relevant symptoms may be 
presented descriptively. 
Benefits and hazards. 
CBT will teach the participants various techniques to facilitate coping with 
depression and may result in an improvement in mood. The results will help clarify 
whether CBT is a viable treatment option for this clinical group. Some participants could 
assume therapy will 'cure' their depression. However, as the title of the booklet implies, 
the therapist will emphasis the principle of managing rather than eliminating depressive 
symptoms. Participants will be informed that they have the right to decline to take part at 
any stage and withdrawal will not affect the service they receive through the Parkinson's 
disease Clinic. Participants who are prescribed antidepressant medication during the 
course of the research will still receive the full psychological intervention. 
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Daily Mood Rating Date from ............. To ...................... 
Keeping a track of your mood can really help to see if there are day to day 
patterns of feeling better or worse. It can also help to provide a way to get 
back to the thought which may lie behind the mood changes both those that 
made you feel low and those that made you feel good. 
Please rate (or ask your carer to rate) how good or bad you felt each day on 
the line below. If you felt good put a pen mark near the start of the line. If 
you felt "so-so" mark near the middle and if you felt low or depressed mark 
near the end of the line. 
Day one 
very happy 94so-so" very low 
Day two 
II 
very happy 96so-so" very low 
Day three 
II 
very happy 66so-so" very low 
Day four 
II 
very happy ctso-so" very low 
Day rive 
II 
very happy 46so-so" very low 
Number of Activities each day Date from ............. To ................... 
Can you write (or ask your carer to write) a list of the things you do on a 
usualday 
Can you or your carer record the number of activities you did during each 
day in the boxes below (e. g. getting the breakfast ready, tidy the house, 
going out). 
Day one 
Daytwo 
Day three 
Day four 
Day five 
Ymddidedolaeth GIG SIroedd Conwy a DInbych 
Conwy & DenbIghshlre NHS Timist 
rim Gogledd Cymru I Bobf Sydd Wedl Cael Anaf 1'r Ymennydd 
Ff6n: 01492807766/807521 Ffacs: 01492516S87 
North Wales Team for People with an Acquired Brain Injury CONSENT FORM 
Tel: 01492807766/807521 Fax: 01492516587 
Title of Project , 
The effectiveness of Brief Cognitive Behaviour Therapy in reducing the 
symptoms of depression In individuals with Parkinson's disease. 
Name of researcher 
Dr Kristina Cole (under the supervision of Dr Frances Vaughan) 
Please delete as appropdate 
I confirm that I have read and understand the information 
sheet for the above study and have had the opportunity 
to ask questions Yes / No 
2.1 understand that my participation is voluntary and 
that I am fee to withdraw at ay time, without giving 
any reason, without my medical care or legal rights 
being affected. Yes I No 
31 understand my GP will be informed that I am taking 
part in this study, and I have seen a copy of this letter. Yes I No 
4.1 agree to take part in the above study. Yes / No 
Name of Patient Date 
Name of person taking consent Date 
(if different from the researcher) - 
Name of person taking consent Date 
r , %byty Cyrnuned Bae Co", Ffordd Hesketh, Bae Co", Conwy LL29 SAY 
i3n: 0 1492 5152 18 Ffacs: 0 1492 S 18 103 1% lwyn Bay Community Hospital, Hesketh Road. Colwyn Bay, Conwy LL29 BAY. It 
ý ýone: 0 1492 515218 Fax: 0 1492 518103 
'ebsite: www. conwy-denbighshire-nhs. org. uk 
Signature 
Signature 
Signature 
NHS 
CYMRU 
WALES 
w 
ci 
Ymddiriedolaeth GIG Slroedd Conwy a Dinbych 
Conwy & Denblghshlre NHS Trust 
INFORMATION SHEET 
0 
The effectiveness of Brief Cognitive Behaviour Therapy In reducing the 
symptoms of depression In individuals with Parkinson's disease. 
You are being asked to take part in the above study. The study has been 
reviewed by the North Wales Health Authority Research Ethics Committee, 
and th6 University of Wales Ethics Committee, Bangor. Before you decide 
it is important for you to understand why the research is being done and 
what it will involve. Please take time to read the following information 
carefully and discuss it with friends, relatives and your GP if you wish. Ask 
your psychologist when she calls, if there is anything that is not clear or if 
you would like more information. Take time to decide whether you would 
be willing to take part. 
What the research Is about 
Long-term illnesses are sometimes difficult to come to terms with. We are 
interested in helping people cope with feeling low when they have 
Parkinson's disease. The aim of the study is to see if a type of therapy 
which has been shown to help people suffering With various illnesses such 
as.. Iong-term pain, can' also help people who get depressed with 
Parkinson's disease. 
Why have I been chosen? 
You have been chosen because one of the forms you filled in while 
attending at the Parkinson's Disease Clinic suggested that there might be 
times when you feel low. We will be asking 20 people who attend the 
Parkinson's Clinic to take part in the study. 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to 
take part you will be given this information sheet to keep and be asked to 
sign a consent form. You are able to withdraw form the therapy at any 
time without giving a reason. If you do withdraw it w1ill not affect the care 
you are receiving through the Parkinson's disease clinic. 
I 
kjQj NHS 
VA V the Erskine House, 74 Conwy Road. Colwyn Bay, LL29 71-D. 
%6) CYMRU 
111V ServIce Tel: 01492 531332 Fax: 01492 535433 WALES 
What will happen to me if I take part? 
I (Kristina Cole) will visit you at your home for one hour per week for seven 
weeks, and then once, a month later to see how you have been getting 
on. To see if the therapy has helped, you will be asked to fill in three 
questionnaires three ' 
times, 1) on the first visit, 2) on the last therapy visit 
and 3) on the visit a month later. It is OK to allow relatives or friends help 
you to fill out the forms. 
it would also be helpful to know how you have been doing each week. 
You may be asked to mention a couple of things (e. g. how low or tired 
you have been or what things Parkinson's disease has stopped you doing) 
in the two weeks before, during and after therapy. 
What type of therapy Is It? 
You will be given a booklet to keep called 
Coping with Depression When You Have Parkinson's disease 
The booklet includes the following sections 
How do I know if I am depressed? 
Whatcanldo? 
How should I change my behaviour? 
How do I change -my depressed thinking? 
How do I solve my problems? 
The psychologist will work With you to try out various ideas mentioned in 
the booklet. These ideas have been show to help people With various 
illnesses. 
Are there any alternative treatments for feeling low? 
Sometimes people who have been feeling low will be prescdbed 
antidepressant medication by their GP or by the Doctors working at the 
Parkinson's Clinic. You can still participate in the research if you cre taking 
any form of medication. 
Are there any disadvantages to taking part? 
A lot of people think that therapy can take all their problems away. This is 
not possible when living with a long-term illness. The aim of therapy is to 
provide people with ways of managing and coping with feeling 
depressed. 
What are the benefits of taking part? 
We hope that the therapy will help. However, as this therapy has not 
been tried with Parkinson Disease, this cannot be guaranteed. The 
information we get from the study Will help us know what type of 
treatments help patients with Parkinson's disease. 
What happens when the therapy ends? 
This therapy is only a short course to help you to cope With your 
depression. At the end of therapy various options may be discussed with 
you. 
Who will know about the results? 
All information will be treated as strictly confidential and will be kept in a 
locked filing cabinet at all times. If you agree to take part, you will be 
asked to sign a consent form, which will be kept in your clinical file. We will 
let your GP know in a letter what is happening, and send a copy of this 
information sheet. A report of the results for the whole group will be 
written by the psychologist and sent to you in the post during the summer. 
Who Is organizing and funding the research? 
Dr Krilstina Cole is organizing and conducting the research as part of her 
training for a Doctorate in Clinical Psychology based at the North Wales 
Clinical Psychology Course, University of Wales, 43 College Road, Bangor, 
LL57 2DG. (Contact no 01 248 386235). No payment will be made for 
taking part in the study. 
What will happen next? 
1) Read through this information sheet carefully and talk it over with 
others if you wish. 
2) 1 will return at a convenient time. If you have any further questions 
feel free to ask. 
3) If you agree to take part, you will be asked to read the consent 
form and sign it. Arrangements will be made for the home therapy 
visits. 
4) If you prefer not to take part, the care you receive through the 
Parkinson's Clinic will not be affected in any way. 
If you would like any further information do not hesitate to contact me 
Dr Mistina Cole 
Tel. 
THANK YOU FOR READING THIS INFORMATION SHEET 
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Conwy & Denblghshlre NHS Trust 
The effectiveness of Brief Cognitive Behaviour Therapy in reducing the symptoms 
of low mood and depression in individuals with Parkinson's disease. 
Dear Dr 
Re 
I am writing to inforni you that your patient has agreed to participate in the above 
research study, and a consent form has been signed. This study received ethical approval 
from the North West Wales Health Authority Research Committee. 
The study aims to evaluate whether brief cognitive behaviour therapy (CBT) can help 
patients with Parkinsons disease who are experiencing symptoms of depression. CBT 
has been demonstrated to be an effective psychological therapy for individuals coping 
with a range of medical conditions including palliative care and chronic pain. However 
it's efficacy with Parkinson's disease has not been established. 
Please find enclosed the information sheet passed on to your patient, which outlines the 
main components of therapy. Participation will not interfere in any way with treatment 
as usual, received through your practice or the Parkinson's disease clinic. If you would 
like any more information, or if you have any questions about the study, please do not 
hesitate to contact me. 
Yours sincerely 
Dr Kristina. Cole 
Trainee Clinical Psychologist 
Contact telephone number before 
After 
Dr Frances Vaughan 
Clinical Psychologist. 
October 1,2002 01492 531332 
October 1,2002 01492 807773 
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Ymddiriedolaeth GIG Slroedd Conwy a Dinbych 
Conwy & Denblghshlre NHS Trust 
The effectiveness of Brief Cognitive Behaviour Therapy in reducing the symptoms 
of low mood and depression in individuals with Parkinson's disease. 
Dear 
Staff working at the Parkinsoes disease clinic may have mentioned a research study 
which is aiming to use brief therapy to help people cope with feeling down in Parkinsorfs 
Disease. You are being asked if you would like to take part in the study. 
I would like to offer you an initial home visit on ................................................ 
The ahn of the visit would be to explain a bit about my self, what the therapy involves 
and to give you the opportunity to ask questions. If you would prefer me not to call, or 
the above time or date is not convenient please do not hesitate to contact me (Kristina. 
Cole) on the number below. If you decide not to take part in the study the care you 
receive through the Parkinsoifs disease clinic will not be affected in any way. 
Yours sincerely 
Dr Kristina Cole Dr Frances Vaughan 
Trainee Clinical Psychologist Clinical Psychologist 
Contact telephone number before October 1,2002 01492 531332 
After October 1,2002 01492 807773 
The Feasibility of Using Brief Cognitive Behaviour Therapy for 
Depression Associated with Parkinson's disease: A Literature Review. 
Kristina Cole 
University of Wales, Bangor 
Frances Vaughan 
University of Wales, Bangor 
This review forms part of Doctoral thesis by the first author supported by the University 
of Wales Bangor, School of Psychology, 43 College Road, Gwynedd, LL57 2DG 
Running head: Parkinson's disease, depression, cognitive behaviour therapy 
Parkinson's disease, depression, CBT. 1 
The Feasibility of Using Brief Cognitive Behaviour Therapy for 
Depression associated with Parkinson's disease: 
A Literature Review. 
Abstract 
Medical personnel and researchers have called for more information on how 
to treat depression related to Parkinson's disease. Cognitive behaviour 
therapy (CBT) has been identified as the National Health Service treatment 
of choice for a range of psychological disorders and is increasingly applied 
to depression associated with chronic medical conditions. The present paper 
will review the relevant literature on CBT treatment effectiveness and the 
nature of depression in Parkinson's disease before suggesting how CBT 
might be adapted to assist this client group. 
Parkinson's disease, depression, CBT. 2 
The Feasibility of Using Brief Cognitive Behaviour Therapy 
for Depression associated with Parkinson's Disease: 
A Literature Review. 
The aim of this paper is to assess the feasibility of using cognitive behaviour 
therapy (CBT) in the treatment of depression in Parkinson's disease (PD) by reviewing 
the relevant literature. CBT has been successful in reducing symptoms of depression in 
people with diverse chronic and neurological conditions (Price & Cooper, 1999; Moorey 
& Greer, 1989; Morley, Eccleston & Williams, 1999), and medical specialists have 
suggested CBT might also be appropriate to use with depression associated with 
Parkinson's disease (Meara & Koller, 2000; Playfer & Hindle, 2001). However as there 
have been few studies endorsing the effectiveness of psychological therapies for PD 
depression, there is a need to examine research in related fields to see if the CBT 
treatment option for PD depression is likely to be effective. 
There are sound clinical reasons for considering the merits of using CBT for 
depression associated with PD including; a) depression affects a substantial proportion of 
people with PD, b) PD depression is often not treated, and c) pharmacological treatment 
approaches do not always seem to work. Findings supporting each of these statements 
will be briefly reviewed before presenting an overview of the principle cognitive model 
of depression and compatible health psychology models. Secondly, the extent to which 
CBT has been helpful with client groups who share some features with people with PD 
will be outlined. Finally, literature on the nature of depression in PD will be covered 
along with the implications for using a cognitive intervention. 
Parkinson's disease, depression, CBT. 3 
Brief Overview of Depression in Parkinson's disease 
Parkinson's disease is the second most common neurodegenerative illness 
(Mastermann & Cummings, 1998). It is an age related disorder, and although some 
people can develop symptoms in the third decade, the average age of onset is reported to 
be seventy (Mutch & Lien, 2001). Characteristic symptoms include akinesia (difficulties 
with movement), rigidity and tremor. These cardinal features would appear to be related 
to the degeneration of doparninergic cells within the substantia nigra, one of three brain 
nuclei comprising the basal ganglia, located in the subcortical region of the brain 
(Bergaman & Deuschl, 2002). In addition to disorders of movement, people can 
experience a range of neuropsychiatric complaints, the most common of which is 
depression (Aarsland et al., 1999). 
Prevalence. Providing a reliable estimate of how many people with PD also have 
depression has proved difficult because studies have employed different assessment 
methods. However two meta analyses have noted prevalence rates of over 40 per cent for 
minor depression and 11 per cent for major depression (Cummings, 1992; Miyawaki, 
Meah, Kormos & Tarsy, 1996). These figures may underestimate the true extent of PD 
depression as symptoms of low mood such as psychornotor retardation and flat affect can 
be masked by those of PD, which implies a potential for missed diagnosis. Whatever the 
current scale of the problem, it would be fair to say that increases in the life expectancy 
of the general population will result in a rise in PD and associated problems such as 
depression. 
Parkinson's disease, depression, CBT. 4 
There are data to suggest that people with PD are more likely to experience 
depressive symptoms than people with other chronic medical conditions. A study of over 
200,000 patient records demonstrated that people with PD have a greater risk for 
developing depression than patients with arthritis or diabetes (Nilsson, Lars, Sorensen, 
Andersen & Bolwig, 2002). The severity of depression in PD has been found to be equal 
to or greater than that found in other neurodegenerative conditions (Levy et al., 1998; 
Gilley, 1990). 
Treatment availabili1y. Given the extent and potential consequences of living 
with depression, it is surprising to find that symptoms of low mood are rarely treated. 
Studies suggest between 50-93% of people with depression associated with PD do not 
receive any treatment, with pharmacotherapy being the only option offered to a minority 
of patients (Richard & Kulan, 1997; Cantello, Riccio, Scarzella, Leotta & Bergamasco, 
1984; Lapane, Fernadez & Friedman 1999; Meara, Mitchelmore & Hobson, 1999). There 
are mixed opinions regarding the use of drugs to treat depression in PD with most 
reviews highlighting the lack of outcome data and the potential toxic effects of 
antidepressant medication as reasons to be cautious (Klaasen et al., 1995; 'Cummings & 
Mastennan, 1999; NINDS, 2001; Bum, 2002). In short, there are substantial disease 
specific reasons why it would be useful to consider the role of psychological therapies for 
depression in PD. 
Overview of Cognitive Behavioural Therapy 
The cognitive model of depression. The most well known form of CBT was 
informed by a theory proposed by Aaron Beck. In the recent reformulation of the model, 
depression is characterized as an experience of primal loss associated with sadness, 
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deactivation, lack of motivation, and withdrawal (Beck,, 1996; Clark, Beck & Alford, 
1999). Beek maintains that biased information processing constitutes the key for 
understanding the disorder and that these biases have implications for how people 
interpret events which, in turn have repercussions for feelings and behaviour. Distorted 
interpretations were hypothesised to stem from core beliefs held in 'meaning making 
structures' or schemas, which are formed on the basis of past experience. Evidence for 
flawed processing is seen in negative automatic thoughts and errors in thinking such as 
covcr-generalisation', 'mind reading' and 'all-or-nothing thinking'. According to the 
model, depressed people hold distorted beliefs about themselves, the world around them 
and are pessimistic regarding the future (Beck, 1967; Wright. & Beck, 1983). Although 
the role of cognitions in mediating depressive illness is fundamental to the cognitive 
model, Beck acknowledged that biological factors, personality traits and life stressors 
could contribute to the development of depression (Beck, Rush, Shaw & Emery, 1979). 
Components of theravY. CBT for depression is a structured therapy which aims to 
help people to identify the maladaptive thoughts contributing to emotional discomfort 
and to replace them with more enabling alternatives (for more detail see, Beck et al. 
1979; Padesky & Greenberger, 1995). This objective is achieved though a process of 
&collaborative empiricism' which involves the therapist and client working together to 
explore the implications of various beliefs for the individual. Socratic questioning is the 
key medium used to guide the client towards identifying, evaluating and, if necessary, 
modifying thoughts (Padesky, 1993). Questioning can take the form of an inference 
chain or 'downward arrow', when the therapist asks a series of progressively penetrating 
questions to uncover maladaptive reasoning. Other features of cognitive therapy include 
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hypothesis testing of the accuracy of thoughts and evaluating the effect of holding 
dysfunctional and alternative beliefs on an individual's mood state. The approach also 
draws upon behavioural techniques such as activity scheduling, graded exposure and 
experiments to evaluate the authenticity of beliefs. 
Mediators of affect. There is no research consensus indisputably identifying the 
mechanisms of -change in CBT (Scott, 2001). Rather there are general assumptions, 
including the belief that improvement is achieved through the transformation of cognitive 
structures, the acquisition of new skills, or the consequence of activating more adaptive 
ways of interpreting experience (Beck, 1996; Gotlib & Harnmen, 1992). Similarly, 
findings are inconsistent regarding which components of cognitive therapy alleviate low 
mood. Several studies have highlighted behavioural activation (Jacobson, et al. 1996; 
Malik, Beutler, Alimohamed, Gallagher-Thompson & Thompson, 2003), others have 
focused on the cognitive elements involved in appraising thoughts (Teasdale & Fennell, 
1982), and finally some believe that non-specific elements of CBT such as the quality of 
the therapeutic alliance play a part in recovery (Garfield, 1998). 
The average number and composition of sessions required to facilitate 
improvement varies over studies. Research findings imply that brief CBT may be as 
effective as long duration therapy for adults of all ages (Shapiro, Rees, Barkham, & 
Hardy, 1995; Gallagher-Thory? pson, Hanley-Peterson & Tbompson, 1990), and both 
group and individual therapy have been shown to be helpful (Charnbless & Ollendick, 
2001). Even though cognitive therapy has been identified as the treatment of choice for a 
range of psychological problems (Department of Health, 2001), it does not necessarily 
follow that it is the best therapeutic option for every client. Factors thought to hinder 
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progress in CBT are entrenched personality styles, poor motivation, low acceptance of 
personal responsibility for change, and pessimism regarding therapy outcome (Ruddell & 
Curwen, 1997; Safran & Segal, 1996). 
Other Health Psychology Models 
Although Beck's model of psychopathology provides the theoretical foundation to 
CBT, other cognitive models have specifically addressed how people interpret the 
experience of illness. These theories offer a health psychology perspective which uphold 
the case for using a therapeutic intervention aimed at modifying unhelpful cognitions to 
alleviate depression. 
The health belief model. This model was initially conceived by Rosenstock 
(1966) and highlights the importance of 'perceptions' of health threat in explaining 
actions. In the main, the approach has been used as a predictive model to explain why 
people do not engage in preventative behaviour. to maintain good health (Sheeran 
Abraham, 1996). The original model proposed that if an individual perceives the threat 
of disease to be credible, following cost- benefits' analysis of consequences, a particular 
health behaviour would be enacted. Applied to the experience of PD, a link with 
perceptions and behaviour could be explained in the following way. If an individual 
perceives a diagnosis of PD to be ominous, s/he may feel that, despite the benefits (e. g. 
'at least PD isn't terminal') the costs are dire (e. g. 'there is no cure'), and may therefore 
choose not to comply fully with medical advice which will have consequences for 
morbidity. 
Transactional model of stress and coping. Appraisal processes again play a 
crucial role in this theory which attempts to explain reactions to major stressors, 
Parkinson's disease, depression, CBT. 8 
including neurological disease (Roberts, Towell, Golding, & Towell, 2001). Whether an 
individual becomes distressed is determined by whether an illness is perceived to be 
harmful, and the beliefs the individual holds about their capacity to cope with it 
(Lazarus, 1966). Coping is defined as 'cognitive and behavioural efforts to manage 
psychological distress' (Lazarus, 1993: p. 237) and can take a number of forms including 
avoidance, distancing, positive reappraisal, controlling, seeking support, accepting 
responsibility, problem solving and confronting (Folkman, Lazarus, Dunkel-Schetter, 
Delongis & Gruen, 1986). The coping strategy adopted may depend on the type of 
demands a particular illness places on the individual. For example, people with PD have 
reported difficulty adjusting to the symptoms of disease whereas people with chronic 
fatigue syndrome report a greater struggle with the acceptance of being ill (De Ridder, 
Schreurs & Bensig, 1998). Evidence suggests that some coping styles may be related to 
poor adjustment, and potentially to the development of depression (Maies, Leventhal, & 
De Riddler, 1996). 
The self-regulato1y model. Unlike the stress and coping theory, Leventhal, 
Nerenz and Steele's (1984) self-regulatory model was specifically conceptualised to 
explain adaptation to illness (Buick, 1997). The process of adjustment involves the 
individual regarding the illness as a problem to be solved. Like other health models, the 
theory highlights appraisal and coping mechanisms. However the theory differs from 
other approaches in the categorisation of factors thought to comprise the personal 
representation of illness. Secondly a dynarnic interaction between three stages of 
processing (representation, coping, appraisal) is proposed. Five components are thotight 
to make up an individual's cognitive representation of a disease, including: 
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I The identity including the label (e. g. PD) and symptoms (e. g. tremor). 
2 Ideas about how the disease was caused. 
3 Belief about the consequences of illness. 
4 Expectations concerning the duratio n of illness, or time-line. 
5 Perceptions of whether the illness can be controlled or cured. 
Individual differences in disease perception will occur because past experience and 
cultural values influence the content of each component of the representation (Leventhal, 
Diefenbach & Leventhal, 1992). The selection of a coping procedure will depend on the 
representation the individual has formed about the illness. Finally, the model proposes 
that people will appraise the effectiveness of their coping strategy and, if it is perceived to 
be unsuccessful, will select a different approach or change the representation of the 
illness. 
The model has provided a framework to investigate responses to a range of 
dissimilar medical conditions (see Petrie & Weinman, 1997). Helder et al. (2002) applied 
the approach to evaluate perceptions, coping strategies and outcomes in Huntington's 
disease (HD). This neurological condition affects many of the same regions of the brain 
as PD, and like PD presents with both physical and cognitive decline over a number of 
years. When compared to the general population, people with HD were more likely to 
use mental disengagement and venting emotions as coping strategies. The overall 
findings indicated that negative perceptions/representations of illness and the coping 
methods of mental and behavioural. disengagement were related to reports of poor mental 
health. 
In summary, the cognitive behavioural. model provides the rationale to explain the 
aims and processes of CBT. Health psychology models give direction to the practice of 
CBT by providing an awareness of the type of issues that people attempt to assimilate 
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when forming a cognitive interpretation of chronic illness. If aspects of a representation 
reflect a biased appraisal of the disease, or the cognitively mediated attempts to cope 
contribute to psychological distress, cognitive behavioural therapy could target these 
domains. 
Outcome literature for CBT 
While few would dispute the need for psychological interventions for PD 
depression, it would be legitimate to argue that CBT should only be considered if the 
evidence for its efficacy in treating depression is robust. Scott (1996) argues that CBT is 
"the most extensively researched psychological treatment for non psychotic, unipolar 
outpatient depressive disorder" (p. 1). Roth and Fonagy (1996) conclude that CBT is an 
empirically validated treatment for a range of psychological problems including 
depression. Like most reviewers, the authors relied on the 'gold standard' meta analyses 
of randomized control trials (RCTs), followed by the guidelines for 'well-established' 
and 'probably efficacious' treatment to determine the effectiveness (see Charabless & 
Hollon, 1998). CBT studies involving four categories of depressed adults especially 
relevant to PD will be discussed here; people with medical problems, neurological 
disorders, older adults, and older adults with cormorbid illness. Reported modifications 
to standard CBT will also be described. 
CBT for depression associated with medical conditions. CBT is being applied to 
an ever-increasing range of medical problems, including illnesses with an enduring, 
fluctuating or terminal course. The basic components of cognitive therapy are invariably 
the same, but the issues addressed vary according to the nature of the illness being 
treated. The effectiveness of CBT for depression associated with chronic pain and 
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cancer is favourable (Morley, Eccleston & Williams, 1999; Antoni, Lehman, Kibourn, 
Boyers & Culver, 2001; Edelman & Kidman, 1999). For chronic fatigue syndrome, an 
illness associated with fluctuating patterns of severity and duration, CBT has - been 
acknowledged as an acceptable treatment provided that the symptoms are not mild or the 
clients are not too disabled to attend outpatients (Price & Cooper, 2003). 
CBT for depression associated with neurological problems. There are few studies 
looking at CBT for depression in neurological conditions, and only one study which used 
CBT with a PD client group. Dreisig, Beckmann, Wermuth, Skovlund and Bech (1999) 
compared outcomes for nine young patients who had received CBT with a treatment as 
usual control (n = 70). The intervention was not clearly described (e. g. "The written 
psychotherapeutic strategies are based mainly on cognitivelbehavioural psychological 
theories" p. 219), and did not specifically target depression. Although the between group 
comparison demonstrated a significant improvement on a range of psychological 
dimensions for the treatment group, the authors did not comment on within group 
changes for depression. Given the fact that the majority of participants reported mild 
symptoms of depression before therapy (90%), it is difficult to determine from this study 
the extent to which a CBT programme purposely targeting depression in PD would be 
effective. 
Mohr's research group have conducted two controlled trials for depression in 
multiple sclerosis. In the first study, an eight-week course of CBT administered over the 
telephone was shown to be more effective than usual-care (Mohr et al., 2000). In the 
second study, the CBT and the antidepressant medication interventions were superior to 
supportive therapy (Mohr, Boudewyn, Goodkin, Boston & Epstein, 2001). 
Parkinson's disease, depression, CBT. 12 
Fleminger, Oliver, Williams & Evans (2003) have advocated CBT as a suitable 
medium for addressing depression following traumatic and acquired brain injury and case 
study reports seem to support this view (Williams et al., in press; Montgomery, 1995). 
Similarly preliminary evidence indicates people with inflammation or injury to the brain 
may benefit from a cognitive intervention (Evans & Williams, 2002). The findings for 
post- stroke depression are less encouraging with Lincoln and Flannaghan (2003) 
reporting no difference between CBT and treatment as usual. 
Weighed on balance, the outcome literature suggests that CBT is a promising 
intervention for people with depression associated with medical problems, including 
some neurologically based disorders, and therefore could also be helpful for PD. 
CBT with older adults. A consideration of older adult literature is relevant 
because the majority of people with PD are in late life. Laidlaw (2001) reports on the 
results of six meta-analyses for late life depression and reached the general conclusion 
that the rates of improvement tend to be comparable to those reported with younger 
adults. 
Two studies using brief CBT illustrate the diversity of outcomes possible with 
older adults. In Rokke, Tomhave and Jocie (2000), ten-session CBT for depression was 
compared with an educational intervention. Clinically meaningful improvement in mood 
was demonstrated for both groups (CBT 71%; educational 61 %) which was maintained at 
one year. The second study hinted that the success of CBT with older adults might 
depend on the severity of depression. Leung and Offell (1993) evaluated a seven session 
CBT intervention and looked at the rates of improvement for people with a major 
depression episode (MDE) and other mood disorders. Ninety-two per cent of the MDE 
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group did not need any contact with mental health services one year on but 50% of the 
'other disorder group' required ftuther support. 
CBT for older people with medical and neurological conditions. Despite the fact 
that an increased association with physical disease has been the only identified factor 
distinguishing older from younger adult depression (Zeiss & Breckenridge, 1997), there 
has been little research looking specifically at the consequences of therapy for older 
adults with medical problems. One exception is Kemp, Corgiate and Gill (1992) who 
compared CBT for depression in older adults with and without physical illness. The 
outcome data demonstrated a 40% improvement in mood in both groups, despite no 
change in levels of functional capacity. Unfortunately the improvements for the disabled 
group were not maintained over time, a factor which was put down to finther 
deterioration in health. 
There is a strong overlap between the illness experiences of people with dementia 
and PD because both disorders typically occur in older adults and the symptoms are 
caused by biological decline. Two studies suggest CBT might be helpful in reducing 
depression when neurological deterioration is taking place. Watt and Cappeluz (2000) 
reported that CBT combined with reminiscence resulted in a 33% improvement in 
depressive symptoms for a group in the early stages of organic illness. Scholey and 
Woods (2003) reported on the outcome and processes of therapy for a case series. On 
average there was a statistically significant improvement in mood. However the degree 
of change varied between individuals, with only two of the seven participants 
demonstrating a clinically meaningful level of improvement. 
Parkinson's disease, depression, CBT. 14 
Taken together the literature on older adults with medical problems suggests CBT 
can lead to a reduction in depressive symptoms but there are individual differences in 
treatment responsivity and it may be difficult to sustain improvement when the individual 
is coping with ongoing illness and further deterioration. 
Modifications to CBT for older ýdults and people with medical conditions. 
As stated previously, the fundamental components of CBT are present in all 
cognitive intervention packages. Modifications refer to adjustments in the way these core 
components are delivered. As older adults often benefit to the same degree from CBT as 
younger adults, specific adaptations to CBT may not be necessary (Gatz et al., 1998). On 
the other hand it seems reasonable to suggest that changes to style might be required for 
older adults who are ill or cognitively impaired (Rybarczyk et al., 1992). When clients 
are in fragile health, Grant and Casey (1995) suggest the therapist may need to supply 
most of the energy to the collaborative process, slow the pace of delivery and use 
memory aids. The same authors also propose that CBT may not be feasible when illness 
becomes so severe that the process of therapy becomes too demanding. 
One of the key challenges facing the cognitive model of depression concerns how 
to address 'realistic' negative cognitions. For medically ill people thoughts about the loss 
of function and poor prognosis are not always distorted. One approach would be to focus 
on enabling the patient to develop coping strategies, such as distraction to override the 
thoughts as they occur (Moorey, 1996). The alternative would be to look for distortions 
associated with the realistic thoughts using standard cognitive techniques. For example, 
when beliefs about the consequences of disease appear rational, further exploration may 
reveal that patients have underestimated their capacity to cope, or hold a misplaced 
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perception that they are a burden to carers (Rybarezyk et al., 1992). Wright, Thase, Beck 
and Ludgate (1993) recommend tackling the 'worst case scenario'. Once the individual 
has confronted the worst eventuality, they may be freed from the intensity of affective 
distress, which places them in a better position to develop more constructive coping 
strategies. 
The case for using CBT for depression in Parkinson's disease 
Given the paucity of evidence for the effectiveness of CBT used with physically 
ill older adults, it is difficult to know whether CBT could be an effective treatment for 
depression in people with PD. Various perspectives are possible. Firstly, as PD patients 
are similar in many respects to adults living with chronic ill health, it would seem fair to 
speculate that CBT would be as beneficial. Just like anyone else, depressed people with 
PD may experience symptoms that stem, in part, from distorted appraisals of the 
difficulties experienced. According to Enright (1997) "there is no psychological or 
physical problem that cannot potentially be assisted by the cognitive behavioural 
approaclý' (p. 1812). Analogously, Laidlaw (2001) argues that CBT is a "relevant and 
accessible therapy precisely because it deals with older people's current concerns, 
whether that is grief, physical limitations following a stroke or general emotional 
distress" (p. 11), and we could add, the impositions caused by PD. 
On the other hand there may be a unique quality to PD depression that could limit 
the effectiveness of a cognitive approach. Many believe that PD depression, akin to post 
stroke depression, is not 'reactive' but biologically mediated, a factor which could 
influence the individual's capacity to engage in and derive benefit from psychological 
therapy (Mayberg & Solomon, 1995; Gareri, Fazio & De Sarro, 2002). Although 
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depression in PD is likely to be the consequence of both biological and psychological 
factors, the only way of establishing whether an organic component will have a bearing 
on treatment effectiveness would be to run a clinical trial. It is possible that CBT will 
need to be adapted to accommodate the physiological factors associated with 
deterioration. In order to appraise the type of modifications that could be required, it 
would be useful to provide a synopsis of the main biological, cognitive and disability 
factors potentially associated with PD depression. To set the scene, it would be of value 
to consider how patients describe their experience of living with PD. 
Lived Experience of Parkinson's disease 
Findings that people with PD are at greater risk of developing depression 
following diagnosis and in the advanced stages of disease (Kaiser, Bodey & Bodey, 
2000), seems to indicate that demands for adjustment vary over the course of illness. 
Qualitative studies have provided a real world perspective on what some of these 
demands might mean on an individual level. Lomas (1999) proposed a transitional 
model of lived experience in which people with PD move though four stages including 
pre-diagnosis, diagnosis, initial adjustment and the transition to the chronic phase. In the 
initial phase patients (n = 9) commented on feelings of sadness when grieving for current 
and future losses, dealing with PD symptoms, and coming to terms with threats to 
identity. 
Some indication of the intensity of the emotional response and meaning of 
diagnosis can be gleaned from the following remark made when a patient realised, that his 
symptoms were consistent with PD. 
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"This predictability was no small part to the entire horror show. One of 
the things I would be losing here was freedom ... I can't overemphasize 
what a blow this prospect of being so unfailingly predictable was to my 
sense of myself as an individual. " (Fox, 2002: 177) 
Lomas (1999) concluded that the key task after diagnosis was to find a way of 
regaining control in order to live with uncertainty and to reduce emotional distress, and if 
this was not achieved patients would be unlikely to move on. Even if adjustment was 
successfully negotiated at one stage, it was suggested that deterioration in symptoms 
could result in a 'resurfacing of dilemmas and emotions which had previously been 
resolved' (p. 52), at a later stage. On a note of caution, attention was drawn to the fact 
that patients often described feelings of sadness or sorrow as 'depression, when it was 
possible that they were experiencing a grief reaction to losses. This observation suggests 
there may be times when transitive states of sadness are incorrectly diagnosed as 
depression. 
The Nature of Depression in Parkinson's disease 
Biological aspects 
A range of identified factors implicate the biological disease process in the 
aetiology and maintenance of depression in PD. Symptoms of anxiety and depression 
can occur before the onset of motor disturbances leading to the proposition of a common 
neurological pathway (Murray, 1996). Rates of depression appear to vary between 
clinical subtypes of PD, with greater depression reported in the akinetic-rigid subtype 
than in the tremor-dominant type (Jankovic, McDermott & Carter, 1990; Starkstein, et 
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al., 1998). These subtypes can be distinguished by the location of severe cell loss within 
the substantia nigra (Kaiser et al, 2000). 
With regard to biochemical differences, some post-mortern studies have found 
lower concentrations of the neurotransmitter serotonin in the cerebrospinal fluid of 
depressed compared to non-depressed patients with PD (Mayeux, Stem, Sano, Williams 
& Cote, 1988). Anatomical studies using positron emission tomography (PET) have also 
found the region of glucose metabolism differs between PD patients with and without 
depression (Ring et al., 1994). 
The 'on-off phenomenon. Motor fluctuations are a common component of PD 
_--affecting-10,50-per--ccent of patients and have been labelled the 'on-off phenomena 
(Menza, Sage, Marshall, Cody & Duvoisin, 1990). Michael J Fox (2002), an actor with 
PD described the 'off phase in the following way, "When I am off the disease has 
complete authority over my physical being. I'm utterly in its possession ... I experience 
the full panoply of classic Parkinsonian symptoms: rigidity, shuffling, tremors, lack of 
balance, diminished small motor control, and the insidious cluster of symptoms that 
makes communication difficult and sometimes impossible" (p. 256). Levodopa. is the 
main pharmacological treatment used to control motor instability but, over time, the 
treatment can become less effective and a proportion of patients will experience 
unpredictable changes in the mobile 'on' and immobile 'off states. Some patients will 
experience mood swings during the 'off period accompanied by feelings of doom, 
helplessness and hopelessness (Nissenbaum, Quinn & Brown, 1987; Matson, 2002). 
Various hypotheses have been offered for mood variations ranging from psychological 
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reaction to the inability to control illness events to changes in doparnine levels (Erdal, 
2001b; Racette et al., 2002). 
Cognitive features 
Patients with PD can develop dementia, with Biggins et al. (1992) recording an 
incidence of 19% in a cohort of 87 patients who were followed over a four year period. 
The risk of dementia increases with age with Mayeux et al. (1990) noting 65% of patients 
with PD over the age of 85 had dementia. About a third of patients' exhibit subtle 
cognitive deficits, and a strong link has been established between cognitive impairment 
and depression (Cubo, Bernard, Leurgans & Raman, 2000). Although basal ganglia 
------dysfimction-is-the-primary-cause--of-P-D., -4he-, effeets-of-&generati r-may lue widespread7- 
due to neural circuit connections between brain systems, particularly those extending to 
the prefrontal cortex. This would explain why cognitive problems traditionally 
associated with the frontal lobe such as deficient problem solving ability, inability to shift 
attentional set, concrete thought and impaired memory processes, often occur (Dubois & 
Pillon, 1997; Lawrence & Sahakian, 1996). 
Biases in information Processing. Within literature evaluating the cognitive 
model of depression, the Stroop task has been used to investigate biases in attention, one 
of the earliest stages of information processing. People with depression are more likely 
to take longer to name emotional words on this task because the content of the words has 
seized attention (Williams, Mathews & MacLeod, 1996). Findings reported by Serra- 
Mestres and Ring (2002) suggest non-depressed people with PD show a similar attention 
processing bias. In an earlier paper the authors argue that PD depression may be triggered 
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by the neurobiological changes that disturbs brain processing, which in turn increases the 
vulnerability to reacting negatively to stressors (Serra-Mestres & Ring, 1999). 
Content of comitions. Several studies have reported that people with PD tend to 
endorse fewer cognitions indicating a negative view of the self, such as guilt and 
worthlessness on the Beck Depression Inventory (BDI) than people without PD (Gotham, 
Brown & Marsden, 1986; Huber, Freidenberg, Paulson, Shuttleworth & Christy, 1989). 
If true, the finding would have implications for the conceptualisation and treatment of 
depression in PD. Methodological shortcomings have been identified in the above 
studies (Nilsson et al., 2002). The results reported by Erdal (2001a), who found no 
------diffe=ce-between-the-c-ontent-of-cognition3-reporttd-by-physicaI 
adults and people with PD, have limited generalisability because only 4% of the PD 
sample had major depression. To summarise, there is tentative evidence that PD 
depression may be associated with fewer negative self-focused cognitions, but more 
research validation is required. 
Disabilily variables linked with depression 
Progressive deterioration. PD is a degenerative condition but the rate and 
severity of the deterioration for each individual is impossible to predict. Uncertainty 
over prognosis affects psychological adjustment in chronically ill people (Mullins et al., 
2001; Neville, 1998), and Baker (2000) found most people with PD worry about the 
progression of disease. One study did not find that 'perceived uncertainty in illness' 
predicted psychological distress in PD, but the authors were careful to point out that the 
participants were selected from support groups so the results may not be generalisable, to 
all people with PD (Sanders-Dewey, Mullins & Chaney, 2001). 
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Falling. Approximately two thirds of people with PD fall within a year, and this 
incidence is two fold higher than that reported for other older adults living in the 
community (Wood, Bilclough, Bowran & Walker, 2002). Problems with balance and 
'freezing' of the lower body are common causes of falling. Findings suggest that people 
who fall are more likely to be anxious and depressed than people who do not fall 
(Ashburn, Stack, Pickering & Ward, 2001; Schrag, Jahanshahi & Quinn, 2001). 
Observable sijzns of disabilily. No quantitative studies have looked specifically at 
how noticeable physical symptoms, such as tremor, difficulties writing and drooling, 
impact on the quality of life or emotional well being of people with PD. On the other 
----hand, -qualitativ, e-data--suggests--that-nuany-peo-ple--wýiffi-PIJ are asharned to be seen in 
public. In Nijhof (1995), half of the people interviewed reported significant difficulties 
coming to terms with visible signs of illness. Schrag et al. (2001) found that reports of 
feeling stigmatised were linked to the severity of depression which gives substance to the 
implication that embarrassment over PD symptoms could play a role in psychological 
distress. 
Implications for Cognitive Behaviour Therapy 
Presumably all the principles identified in literature covering CBT for chronic 
illness and older adults would hold for the depressed patient with PD. The therapist may 
need to consider how to tackle realistic negative thoughts concerning the disease 
progress. If the adult is older, it may be necessary to think about whether changes to the 
structure, duration and mode of delivery are required. Whether a psychological 
intervention can work for a disorder with an assumed intractable organic basis is a 
controversial issue which requires ftu-ther comment. In the final section, an argument 
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will be made supporting the use of CBT with depression compromised by 
neurodegenerative factors. Also the preceding findings on the nature of PD depression 
will be used to consider how CBT might be used effectively followed by considering the 
type of adaptations and themes anticipated arising during therapy. It should be noted that 
many of the ideas presented are speculative. 
Can CBT be effective with an organically mediated disorder? 
So far we do not have sufficient evidence to give a conclusive answer to this 
question. Whilst the biological aspects of PD have been discussed in the context of the 
implications for drug treatment (NINDS, 2001; Bum, 2002; Cummings, 1992), there has 
----been-little-inforrnation-on-th 11 bigifillcmi ical therapy. Psycfu-atric 
literature has tended to argue that psychological approaches could be beneficial when 
depression is 'reactive' rather than endogenously based (Lieberman, 1998). The 
cognitive theory however, maintains that a biological component should not preclude a 
psychological approach because the model always acknowledged that organic factors 
might be significant in the disorder (Clark, Beck & Alford, 1999). Even if PD depression 
is organically determined (as is implied by the possible link between dopamine levels and 
depression) it should still be possible to use a cognitive intervention effectively. 
To use an illustration, if the increased sadness that occurs during motor freezing is 
caused by neurochemical changes, CBT might still be able to promote more effective 
coping. The therapist might help the individual to prepare in advance for the type of 
cognitive distortions likely to happen during the 'off period and try out more 
encouraging alternatives. The use of cognitive methods may enable the individual to 
break the vicious * circle of depression exacerbated by the continual strearn of 
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dysfunctional cognitions, irrespective of the initial cause. In this situation, the emphasis 
would not be on 'curing' low mood but finding a way to manage the reactive responses in 
order to maintain the most optimistic outlook. 
AdUtations to cognitive behaviour thergRy 
Careful attention needs to be given to how particular symptoms of PD may affect 
therapy. There is very little information on the impact of subcortical. deterioration on 
therapy responsivity, but some evidence to implicate cognitive dysfunction with poor 
treatment outcomes (Jarrett, Eaves, Grannemann & Rush, 1991). Nonetheless as Jones, 
Miller, Williams and Goldthorp (1997) argue when discussing the application of CBT to 
------peopk-with-inteUeetual-disahilities-who-may-be-compromised-by-similar-pm cesmg- -, -- 
problems as people with PD, it should be possible to develop methods to overcome the 
difficulties posed by cognitive deficits. Crews and Harrison (1995) provide a 
comprehensive account of the neurological basis of depression and hypothesise 
adaptations for CBT, which have relevance for the present consideration of PD. For 
frontal lobe dysfunction, they identify the following deficits that have the potential to 
impede the effectiveness of cognitive therapy including, impaired capacity for self-talk, 
literal interpretations of situations and difficulties processing and retaining new 
information. Rather than discount CBT on account of these deficits, the following 
recommendations were made; a) to encourage the person to verbalise rational thoughts, 
b) incorporate frequent discussions of abstract thinking within the therapy session, c) to 
enlist the support of carers to encourage practice and repeat concepts between sessions, 
and d) to prepare written material. Stated concisely, the therapist would need to facilitate 
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the process of guided discovery more conscientiously than would be necessary with a 
cognitively unimpaired individual. 
Themes anticipated to arise in therap 
Former studies suggest illness-focused rather than self-defamatory cognitions 
commonly feature in the depressive experience of patients with PD (Huber et al., 1989; 
Gotham et al., 1986). Understandably, most patients worry about the inability to predict 
prognosis (Backer, 2000). A useful cognitive strategy could be to demonstrate that it is 
not the uncertainty in itself which is causing distress, but the thoughts connected to 
uncertainty (White, 2001). If the collaborative discussion reveals that the individual has 
----created--a-grossly-distorted-image-of-future-events-or lias underestimated theirTerceive-d --- 
capacity to cope, hopeful but realistic thoughts could be encouraged, and the Socratic 
exploration could build confidence in the individual's capacity to handle changes. 
For other anticipated concerns, cognitive strategies have been used to reduce the 
fear of falling and increase physical activity in the general population (Tennstedt, 
Lawrence & Kasten, 2001) and should be suitable for PD. Like falling, fear of being 
seen with signs of disease can lead to a decrease in social activities, an avoidance strategy 
which could maintain psychological difficulties. Cognitive and behavioural techniques 
can be utilised to test the reality of predictions of how others will respond to observable 
markers of disease, and build coping strategies should the 'worst possible scenario' occur 
(e. g. a person passing a rude comment when PD symptoms cause the individual to shuffle 
or stumble in public). 
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Conclusion 
A recent review labelled the treatment of PD depression as 'something of a 
blackhole' with very little evidence-based information to suggest what might work (Bum, 
2002: p. 45 1). Whether CBT can effectively ameliorate symptoms of depression in 
people with this complex degenerative condition is, at present, an open question. Perhaps 
the dearth of published research in this area is a testimony to how difficult it has been to 
use psychological approaches with PD. Also we do not know how much relevance the 
CBT efficacy literature in the related fields of older adults and chronic illness will have 
for the PD population. The only established certainty is that people with PD depression 
-----are--a-vulnerableý-often-negleoted-group. -Tius-would-appear-t"rovide-a-sound-clinkal---- --- 
basis to attempt to confirm the validity of CBT in this population. 
Feasibility studies would not only provide crucial clinically relevant information 
on how to manage low mood in PD, but also build theoretical understanding in 
previously neglected areas. The cognitive model presumes that the therapeutic processes 
involved in evaluating dysfunctional thoughts can be applied universally. People with 
PD depression not only have to adjust to numerous and ongoing impairments, they have 
to contend with negative thoughts that often have some basis in reality, and their affect 
may be determined, in part, by neurodegenerative changes. So far, with the exception of 
Crews and Harrison (1995), little has been written about the neuropsychology of 
depression and its implications for cognitive. Even less is known about the consequences 
for therapy in depression associated with subcortical disease, including PD. If cognitive 
therapy does not work for patients with PD, one would need to question whether the 
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model accounts adequately for 'rational cognitions' and the potency of organic 
moderators of treatment. 
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Brief Cognitive Behavioural Therapy for Depression 
Associated Nvith Parkinson's disease: 
A Single Case Series. 
Abstract 
The feasibility of a brief home based cognitive behavioural intervention for depression 
associated with Parkinson's disease was evaluated. Five depressed patients between the 
ages of 54 and 82 attending a movement disorder clinic agreed to participate. Outcome 
was assessed using mood and quality of life inventories (Beck Depression Inventory; 
Geriatric Depression Scale; Parkinson's Disease Quality of Life Questionnaire). Four 
individuals demonstrated a clinically reliable reduction of symptoms according to the 
GDS scores, %ith greater improvement reported for the two individuals NNith more severe 
pre-therapy levels of depression. The BDI findings suggested most of the improvement 
related to the cognitive dimensions of guilt, pessimism and failure. Overall, the change in 
mood was not accompanied by an enhancement of perceived quality of life, and little 
variation in the frequency of activities was reported over the course'of therapy. Possible 
explanations for the findings are considered along with implications for theory and 
clinical practice. 
Parkinson's disease, depression, CBT. 2 
Brief Cognitive Behavioural Therapy for Depression 
Associated Nvith Parkinson's disease: 
A Single Case Series. 
Introduction 
Few therapeutic approaches have received more research attention in recent 
decades than cognitive behavioural therapy (CBT). The sphere of health psychology has 
seen CBT b6ing tried with an evcr-increasing range of medical problems including 
chronic pain, cancer and neurologically based disorders such as multiple sclerosis and 
brain injury (Morley, Eccleston, & Williams, 1999; Antoni, Lehman, Kibourn, Boyers & 
Culver. 2001; Mohr, Boudcwyn, Goodkin, Boston, & Epstien, 2001; Evans & Williams, 
2002). Medical specialists are beginning to consider the role of CBT for depression 
associated with Parkinson's disease (Mcara & Koller, 2000; Playfer & Hindle, 2001), but 
so far there have been few published studies evaluating its effectiveness. 
Parkinson's disease (PD) is a chronic age related neurodegencrative condition, 
characterised by motor disability, tremor and rigidity. It has been estimated that I in 100 
of the over 60 population will develop the disorder (Cummings & Masterman, 1999). 
Depression is a common problem in patients --vith Parkinson's disease (Aarsland et al., 
1999). Estimates of the frequency of PD depression have varied in accord with the 
assessment methods used, but two meta analyses suggest a rate of 40% (Cummings 1992; 
Miyawaki, Meah, Kormos, & Tarsy, 1996). 
Extensive literature has attributed the high prevalence rates to a range of potential 
sources. From these idcntirted factors, authors have speculated that PD depression may 
be organically determined, a psychological reaction to consequences of disease or a 
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combination of both (Mayberg & Solomon, 1995; Schrag, Jahanshiahi & Quinn, 2001; 
Bum, 2002). Findings potentially supporting the biological perspective include the 
association between depression and dopamine levels (Racette et al., 2002), subtype of 
Parkinson's disease (Jankovic, McDermott & Carter, 1990; Starkstein et al., 1998), 
serotonin levels (Mayeux, Stem, Sano, Williams, & Cote, 1988), degree of cognitive 
impairment and information processing (Cubo, Bernard, Leurgans & Raman, 2000; 
Serra-Mestres & Ring, 1999). For the reactive hypothesis, depression has been linked to 
changes in the quality of life (Karlsen, Larsen, Tandberg & Mealand, 1999), falling 
(Ashburn, Stack, Pickering & Ward, 2001) uncertainty of prognosis and increased 
disability (Backer, 2000; BroAn, MacCarthy, Gothan, Der & Marsden, 1988), levels of 
functional activity (Liu ct at., 1997), the inability to control motor freezing (Matson, 
2002) and shame (Nijhof, 1995). 
The complexity of variables associated with. PD depression has provided a 
treatment challenge for medical personnel attempting to help. The literature suggests that 
between 50-93% of people with depression in PD are not treated (Lapane, Femadez & 
Friedman, 1999; Meara, Mitchelmore & Hobson, 1999). Even though a minority of 
patients are prescribed antidepressant medication, the evidence for its effectiveness 
remains equivocal (NINDS, 2001). Thus, there would appear to be a clear rationale for 
trying psychological approaches with this population. 
The main theory informing the development of CBT was proposed by Aaron 
Beek. The model stated that during depression people tend to perceive events in an 
overly negative or distorted manner (Beck, 1995). These appraisals are thought to 
determine how the individual feels and behaves. CBT is a structured, problem orientated 
approach that involves the client and therapist collaborating together to identify patterns 
of unhelpful thinking and replace them with more reasonable alternatives. Treatment 
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comprises sharing with patients the cognitive conceptual isation. of their problem, 
behavioural strategies to provide evidence to counteract unhelpful thinking and an 
exploration of the client's disordered thoughts. 
A study by Dreisig, Beckmann, Wermuth, Skovlund and Bech (1999) has 
highlighted the potential for using CBT with PD. Although therapy did not specifically 
target depression, individually tailored interventions for nine young PD -patients indicated 
that average scores on a Psychological Profile Questionnaire demonstrated significant 
improvement for the treatment group compared to the control group. For clients who 
share similar problems as people with PD, CBT is becoming established as an effective 
treatment. Laidlaw's (2001) review of six meta-analyses for late life depression 
concluded that the outcomes of CBT for older people are comparable to those found with 
younger adults. For depression associated with neurological conditions, CBT has been 
shown to be more effective than supportive therapy for multiple sclerosis (Mohr et al., 
2001), and preliminary findings indicate CBT can help people with depression and 
dementia (Scholey & Woods, 2003). Cancer patients and people experiencing chronic 
pain or fatigue appear to fare better when receiving CBT than people who receive 
treatment as usual (Morley et al., 1999; Greer et al., 1992; Price & Cooper, 2003). These 
findings suggest CBT should be appropriate for people with depression associated with 
Parkinson's disease. Furthermore it ought to be possible to look at patterns of unhelpful 
thinking regardless of whether the content of thoughts are related to organic or 
psychosocial changes. 
Brief psychological interventions are increasing in popularity (Curwen, Palmer, & 
Ruddell, 2000). In a sample of older adults, the majority of whom had a cormorbid. 
chronic illness (82%), ten-session CBT resulted in an improvement in mood which was 
maintained one year later (Rokke, Tornhave & Jocie, 2000). Leung and Offell (1993) 
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evaluated a seven-session CBT and looked at the reduction of depressive symptoms 
according to DSM diagnostic categories and found that ninety two per cent of people 
with severe depression did not need to contact mental health services within the 
following year. - Mohr et al. (2000) found eight-session telephone administered CBT was 
helpful for people with depression associated with multiple sclerosis. 
Although these findings suggest that brief CBT holds promise for treating PD 
depression, it would be worth considering features of the disease with the potential to 
influence the success of therapy. Parkinson's disease is primarily caused by basal ganglia 
dysfunction, and the slowness of processing characteristic of this area is likely to impact 
on the individual's capacity to process information during therapy. Likewise, a 
proportion of PD patients experience motor fluctuations which have been labeled the 'on- 
off phenomena (Menza, Sage, Marshall, Cody & Duvoisin, 1990). As switching off can 
be accompanied with communication and concentration difficulties, it would seem 
reasonable to assume that the patient would find it harder to engage in collaborative 
explorations during these periods (Kaiser, Bodey & Bodey, 2000). Cognitive deficits 
also feature in Parkinson's disease (Dubois & Pillon, 1997), including those problems 
traditionally associated with frontal lobe dysfunction such as concrete thinking, and 
impaired memory. Although suggestions for modiýdng cognitive therapy to address 
these problems have been proposed, there is limited information evaluating whether they 
are effective (Crews & Harrison, 1995). 
1 
Depression, if left untreated is likely to lead to poor outcome for the patients in 
terms of increased disability and morbidity (Cummings & Masterman, 1999). As low 
mood can reduce functional activity beyond the impairment already caused by motor 
disability, it would seem reasonable to suggest that treating mental health would 
contribute to improving the patient's quality of life. In the following study, a structured 
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self-help booklet will be used as an aid to brief CBT for depression associated with 
Parkinson's disease. The association between quality of life and depression led us to 
consider whether any change in depressivc symptoms would be accompanied by change 
in patients' perceived quality of life. A home-based intervention was utilized in order to 
overcome the practical difficulties patients would face travelling to a clinic. 
2. Method 
2.1 Design 
The effectiveness of a brief form of CBT for depression in Parkinson's disease 
was evaluated using an A-B design with follow-up. Patients completed pre, post and 
follow up outcome measures. They also kept pre-treatment baseline measures of activity 
frequency and mood level for 5 or 10 days prior to intervention. Following baseline, 
CBT was delivered following the contents of a self-help booklet entitled, 'Coping with 
Depression when you have Parkinson's disease' (Beck, 2000). Therapy comprised one 
sixty minute session per week for seven weeks. One month following completion 
patients were asked to repeat baseline measures. 
2.2 Participants. 
Four female and three male patients meeting the clinical diagnosis for PD 
according to the UK Brain Bank criteria for probable Parkinson's disease, were 
consecutively referred for brief therapy directly from a Movement Disorder Clinic based 
in a North Wales hospital. Two patients were not included in the clinical trial because it 
was decided that a different therapeutic intervention would be more appropriate. One 
male (age 83) was experiencing hallucinations and deluded thought as a side effect of 
parkinsonian medication. The intervention utilised principles of CBT for psychosis 
(Kingdom, 1998) and supportive psychotherapy for his carer. A second female patient 
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(age 79) was experiencing an unpredictable severe form of akinesia during sessions. 
Supportive psychotherapy was offered until practical assistance for PD symptoms could 
be obtained. None of the remaining five patients were experiencing symptoms of known 
dementia and all were taking antipark-insonian medication. Webster scale scores (1968), 
measuring the severity of PD indicated that four patients were moderately disabled and 
one patient (case 3) was in the advanced stage of disease. Scores on the Hoehn and Yahr 
scale (1967) which categorized patients according to motor ability on a 5-point scale 
ranged from 2-4. A diagnosis of possible depression in PD had been made on the basis 
of scores of 5 or more on the GDS-15 Geriatric Depression Scale. Two of the five 
patients were taking antidepressant medication. 
2.3. Measures 
The Geriatric Depression Scale (GDS-15, Sheikh & Yesavage, 1986). 
The GDS-15 is a short inventory requiring a simple 'yes/no' response to fifteen 
items. The scale was designed to measure symptoms of depression observed in the older 
adult population and has recently been used as a screening instrument in a Parkinson's 
disease prevalence study (Meara, Mitchelmore & Hobson, 1999). Research comparing 
the GDS with other depression scales has established the inventory as a reliable and 
sensitive measure of depression in older adults with medical conditions (Pomeroy, Clark 
& Philp, 2001). 
The Beck Depression Inventory - 11 (BDI-II, Beck & Steer, 1993). 
The BDI-II contains 21 items, each scored 0 to 3, measuring symptoms 
commonly associated with depression. The BDI is a key research tool used to measure 
outcomes following CBT with older adults, and depression associated with medical 
problems (Laidlaw, 2001; Mohr et al., 2001). It has been established as a reliable and 
valid measure of depression in PD (Levin, Llabre & Weiner, 1988), and a cut off criteria 
Parkinson's disease, depression, CBT. 8 
for diagnosing depression in the Pl) population has been proposed (Leentjens, Verhey, 
Luijckx & Troost, 2000). 
Parkinson's Disease Quality of Life Questionnaire (PDQL; De Boer, Wijker, 
Speelman & De Haies, 19965. 
The PDQL is a disease-specific instrument comprising 37 items, scored I to 5, 
looking at PD symptoms, systemic symptoms, emotional and social functioning. The total 
score gives an indication of the patient's overall perceived quality of life. Hobson, 
Holden and Meara (1999) found the anglicised version of the PDQL was a useful disease- 
specific measure with good convergent and discriminative validity. 
During baseline, therapy and follow-up, patients monitored mood level using a 
visual analogue scale adapted from Dick et al. (1995) manualised treatment for older 
adults. Patients were asked to provide a rating of how low they were feeling on a range 
from 0 'very happy' to 10 'very low'. They also provided a frequency count of the 
number of activities engaged in per day. Self-monitoring of mood and activity frequently 
feature together in depression research (Harmon, Nelson & Hayes, 1980), and commonly 
occur in CBT and PD studies (Rokke, Tomhave & Jocie, 2000; Kemp, Corgiat & Gill, 
1992; Leung & Orrell, 1993; Liu et al., 1997). The use of a simple frequency count of 
activities along with the visual analogue scale of Dick et al. (1995) have not featured 
together in published literature on PD but fulfilled the criteria for an unobtrusive repeated 
measures assessment (Barlow, Hayes & Nelson, 1984), and was believed to be less taxing 
for people experiencing micrographia. 
2.4 Procedure 
Following referral, a home visit was arranged to explain the aims and structure of 
the intervention. Patients who had given informed consent were given a copy of the self- 
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help booklet to read and asked to complete baseline measures 5 or 10 days prior to 
treatment. The CBT protocol as guided by Beck (2000) is shovýn in table 1. Therapy 
was delivered in the patient's home by the first author who had appropriate training and 
experience in CBT. Individual weekly supervision was provided by the second author. 
Insert Table 1. here 
All patients followed the same structure as outlined in the protocol. The first 
section outlined the symptoms typical of depression and gave examples of depressed 
thinking (e. g. 'Life isn't worth living any more'). The behavioural component provided 
an example of an individual with PD whose mood had improved after behavioural. 
activation and encouraged the patient to plan and attempt activities during the coming 
week. The cognitive component contained four steps to help the patient identify and 
evaluate the 'reasonableness' of negative thoughts (e. g. 'I am a burden to everyone'). The 
therapist worked through the steps with the patient and put together a written summary 
along with a clit-kal formulatioft for the client to refer to as a memory aid. In session six, 
a difficult situation was problem solved using the steps outlined in the section and issues 
associated with compliance with medical advice were covered. On the final visit the 
therapist reviewed the content of previous sessions and discussed how they might apply 
the principles in the future. During the follow up appointment the patient shared how they 
had been managing since the end of therapy and options for ongoing mental health 
problems were addressed. 
Results 
People with Parkinson's disease are a heterogeneous population, and this 
variation was demonstrated in the diversity of issues raised in each section of the self- 
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help booklet. Three patients (cases 1,2 and 4) did not acknowledge particular cognitive 
identifiers of depression highlighted in the psychoeducation section (e. g. worthlessness 
and guilt). The rccommendation to introduce activities to lift mood ýN-as not always 
straightforward as individuals with mild depression were already attempting to maintain 
an active life, and those with more severe depression tended to have complex physical 
problems that hindered the application of behavioural, work. The concerns covered 
during the cognitive restructuring and problem solving components of therapy are shown 
in Table 2., and a synopsis of the process of intervention per client is presented below. 
Some personal identifiers have been changed. 
-- - ----------- - ---- -- ft ... . ....... ....... - ------------ - ---------- --- -- 
Insert Table 2. here 
Case I was a51 -year-old married male who had been diagnosed with early onset 
Parkinson's disease two years previously and had no previous mental health history. As 
his PD symptoms advanced he was forced to give up employment. He admitted that his 
only concern was the fear of falling. The behavioural evaluation revealed that he was 
attempting to maintain an active life which included starting new hobbies, and using 
various strategies to compensate for movement impairment. Freezing was observed as he 
tried to walk through doorways and symptoms associated with switching off were noted, 
which led to shorter sessions on three occasions. The psychological component of his 
fear was evaluated during cognitive restructuring, and an initial worsening of mood 
occurred (see Figure 1, session 3). The GDS score demonstrated a reduction in depressive 
symptoms, although BDI and self-ratings of mood suggested ongoing symptornatology, 
possibly maintained by concerns regarding the outcome of forthcoming major surgery. A 
request was made for an occupational therapy assessment to evaluate the practical 
Parkinson's disease, depression, CBT. II 
strategies for managing falls in the home. During the follow up appointment the therapist 
needed to go over apparently forgotten material previously covered in therapy. 
Case 2 was a 72-year-old married female who had been diagnosed with late onset 
tremor dominant PD two years previously and had a previous mental health history of 
mild claustrophobia. She acknowledged minimizing her mood symptoms because it 'was 
rooted in her generation' not to admit to feeling low. Her PD symptoms were relatively 
minor and the behavioural, Nvork indicated that she was keeping up an active social life 
which involved visiting family, fflcnds and former work colleagues. She had not told 
many people she had a diagnosis of PD and would sit on her hands in public if the tremor 
was visible. Symptoms of low mood occurred during the morning when, she reported the 
internal tremor occurred, and she started to ruminate on what her prognosis would be. 
Her thoughts were linked to the belief that she would deteriorate in the same manner as 
her mother-in-law who had died following a dementia related illness. Her symptoms of 
mild depression as measured by the GDS and self-ratings of mood (see Figure 1) 
improved over the course of therapy. The follow up appointment showed a return of 
some symptoms which may have been attributable to death of a friend during the 
previous week. 
Case 3 was an 83-year-old married female who had received a diagnosis of PD six 
years previously, and had no previous mental health history. Her husband undertook 
many of the household duties due to the fact that she was incapacitated with many health 
problems, including fluctuations in PD movement impairment, frequent headaches, poor 
sleep, urinary infections and back pain. The pervasiveness of her health problems made 
it difficult to introduce pleasurable activities but it was possible to encourage her to plan 
replies to her daughter's email messages. During cognitive work this lady was very 
pessimistic about the outcome of therapy because she believed she was too old and ill to 
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try anything new. When the therapist shared how other people with PD were managing 
their thoughts, she became more optimistic and began smiling in the final three therapy 
sessions. The outcome measures confirmed an improvement in mood had occurred 
although she was still not symptom free and her own self-reports demonstrated little 
variation (see figure 1). She did not want to continue with therapy nor did she want to 
take antidepressant medication because she felt she was feeling much better. 
Case 4 was an 80-year-old married male who had received a diagnosis of PD 
three years previously and had a previous history of health anxiety which he had 
managed effectively before retirement. He had mild symptoms of tremor dominant PD, 
but had given up most activities including gardening and social outings. His low mood 
was linked to concerns about developing a particular health condition, which had been 
triggered by literature suggesting the condition was a common complication in PD. It 
was difficult to motivate this client to introduce any pleasurable activities but by the final 
session he had started to visit an old friend once a week. The irrational content of his 
thoughts was readily acknowledged, especially given that he had never experienced the 
problem he was concerned about. Although this patient was very appreciative of the 
therapy visits, there was little change in his mood levels, quality of life or activity over 
the course of the intervention. Options for continuing therapy were discussed, and it was 
decided to focus on strategies suggested by the physiotherapist before continuing with 
psychological therapy. 
Case 5 was an 82-year-old married female who had experienced depression 
following the suicide of her mother thirty years ago. Depression recurred following the 
PD diagnosis five years previously. The patient firmly believed her symptoms of 
depression were closely tied to fluctuations in her PD symptoms and the therapist's 
observations over the course of the intervention concurred with this view. She was 
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willing to comply with suggestions for behavioural activation but found it difficult to 
enact them when PD symptoms were severe. During cognitive work she appreciated the 
opportunity to discuss thoughts related to becoming a burden to her family. Her mood 
improved substantially over the course of therapy, as did her perceived quality of life and 
the number of pleasurable activities engaged in. Other than the fluctuations in PD 
symptoms and therapeutic intervention, no other extraneous factors could be identified as 
potential contributors to improvement. As cognitive work revealed that she believed PD 
was a punishment for not preventing her mother's suicide, it was felt she would find 
further therapy helpful and she agreed. 
Scores on depression inventories and PDQL pre, post-treatment and follow-up for 
each participant are shown in Table 3. All pre-treatment scores on the GDS fell within 
the clinical range (recommended cut off point 5) and three individuals had BDI-11 scores 
above the cut off point of 16 recommended to identify PD depression (Leentjens et al., 
2000). An improvement in symptoms was shown by the lower scores in all mood 
measures following treatment, although the degree of reduction was marginal for people 
with less severe pre-therapy depression (Cases 1,2, and 4). The changes in BDI-II scores 
following treatment were no longer evident one month later for Cases 1 and 2. Both of 
these individuals had experienced significant stressors (e. g. death of friend following 
terminal illness; preparation for major surgery) in the week prior to the follow-up visit. 
Apart from case 5, the data suggested that changes in mood did not appear to be linked to 
an improvement in the client's perceived quality of life. 
---------------------------------------------------------------------------------------------- ft ------ - --- 
Insert Table 3. here 
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In order to determine whether the levels of improvement observed were clinically 
meaningful, the Reliable Change Index (RCI, Jacobson & Truax, 1991) was calculated 
for the pre and post intervention difference for the GDS, BDI-H total scores, and BDI-II 
factors (see Table 4. ). The findings suggest a clinically reliable change had taken place 
for four patients according to the total GDS scores (test re-test reliability 0.85; Yesavage 
et al. 1983). 
------------------------------------------------------------------------------------------------------------ 
Insert Table 4. here 
The BDI-II data (test-retest reliability 0.93; Beck, 1996), confirmed a reliable 
change for the two patients who had more severe pre-therapy depression. For these latter 
individuals, the scores for BDI factors (Steer, Ball, Ranieri & Beck, 1999) indicated a 
trend for more change in the cognitive domain, although the results were only significant 0 
for case 5, assuming the conservative test-retest reliability score of 0.85. These patients 
reported less sadness, pessimism, feelings of failure and guilt. 
Figure 1. shows the self-reported recordings of mood level and frequency counts 
of activities throughout the baseline, intervention and follow-up period for each 
individual. It is worth noting that trends for improvement in mood can be difficult to 
interpret when fýctors such as feeling physically unwell have the potential to influence 
how people respond. Overall there was little variation in the frequency of reported 
activities throughout the intervention. 
In Case 1 there was no obvious decline in self-rated depression during the 
intervention phase. Rather during the third session there was a noticeable worsening of 
mood which corresponded to the identification of underlying assumptions. There was a 
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trend for improvement during the intervention phase for the second client, followed by a 
small deterioration during the follow up period when the client was grieving the loss of a 
friend. The trends shown in Case 3 were particularly difficult to interpret given that the 
improvement in mood supported by the RCI calculations (e. g. less sadness, crying and 
pessimism) did not correspond with the patient's weekly reports which showed little 
change. Interestingly, the therapist noted an increased frequency of smiling during the 
final therapy sessions which suggested that an improvement in mood might have 
occurred. It is possible that personality factors and ill health during sessions had 
influenced the style of responding for this client. Consistent with the questionnaire data, 
there was no obvious pattern of improvement or deterioration for client 4. A clear 
improvement in mood was apparent at the start of intervention for case 5, which was 
maintained after therapy was completed. Like Case 1, the Socratic focus on identifying 
underlying assumptions was however associated with an initial worsening of symptoms. 
Insert Figure 1. here 
4. Discussion 
Overall, the results from this preliminary case series indicate that brief CBT may 
help to alleviate symptoms of depression in adults, particularly those with greater severity 
of depression in PD. The rate of improvement reported for the two cases with more 
severe depression, is consistent with outcomes from CBT group design research assessing 
adults with similar age and illness circumstances (Mohr et al., 2001; Leung & Orrell, 
1993). 
The finding that medically ill participants with less severe depressive symptoms 
did not benefit to the same degree and were not able to sustain the small gains made over 
time, has also been reported elsewhere (Price & Cooper, 2003; Kemp Corgiate & Gill, 
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1992). A number of possibilities need to be taken in to account when interpreting this 
finding. It would be reasonable to claim that a radical shift in mood is less likely for 
people with mild depression. It is also possible that other factors influenced treatment 
responsivity including the occurrence of major stressors, comorbid illness or cognitive 
deficits. Cases I and 4 reported symptoms of anxiety, which is consistent with literature 
suggesting that 67% of people with PD depression have a diagnosis of anxiety (Menza, 
Robertson-Hoffman & Bonapace, 1993). Cognitive impairment as a potential moderator 
of treatment was also evident when the therapist needed to remind the first two clients 
concerning material previously covered. 
Since the validity of the outcome measures is a crucial consideration in any study, 
it is also worth drawing attention to the implications of the disparity between the BDI and 
GDS-15 in initial diagnostic evaluations and clinical outcomes. The GDS-15 has been 
shown to have acceptable specificity comparable to other short depression scales for 
medical patients (Pomeroy et al., 2001). The use of the BDI has been qudstioned on the 
basis that somatic items might confound interpretation (Williams & Richardson, 1993). 
Consequently, based on the findings of Leentjens et al. (2000) a high cut-off of 16 was 
adopted to limit the chances of false positives in PD. Unfortunately as Leentjens noted, 
this level of specificity carries the risk of low sensitivity, which means that depression 
could be missed. Given that the GDS also contains somatic items, one might conclude 
that the designated cut off has the potential to overrate and the BDI to underrate the 
presence of depression in PD, which suggests we cannot be sure that the initial 
assessments of our milder cases were completely accurate. This classification dilemma is 
not new to PD depression research (Bum, 2002), and illustrates the need to find scales 
which effectively discriminate between depressive, cognitive and somatic symptoms of 
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PD. The has been identified as a key research initiative by the National Institute of 
Neurological Disorders (NINDS, 2001). 
Given the hypothesized link between quality of life and depression it was 
interesting to note that, apart from one patient, there was no obvious connection between 
improvement in mood and changes in perceived quality of life (Karlsen, et al., 1999). 
For most individuals, PD symptoms were either unremitting or worsening, which raises 
the possibility that physical frailty may prove to be more decisive for perceived quality of 
living in PD patients than poor mental health (De Ridder, Schruers, & Bensing, 1998). 
The negligible variation in activity frequency for four individuals was also 
unexpected. Efforts to increase the number of pleasurable activities were generally 
ineffective because disease factors often constrained what could be done (e. g. risk of 
falling in poor weather conditions; switching ofo. From the perspective of the cognitive 
model, it is assumed that increasing pleasurable activities will contribute to an 
improvement in mood by providing evidence to counteract dysfunctional cognitions 
(Beck, Rush, Shaw & Emery, 1979). Recent and controversial findings have suggested 
that the behavioural. component of CBT can lead to greater change in mood than the 
attempt to modify thinking (Jacobson & Gorter, 2000). The question raised by the present 
and similar findings (Kemp, Corgiate & Gill, 1992; Leung & Orrell, 1993) concerns what 
components of therapy facilitate improvement when the scope for increasing activity is 
restricted by poor health. Interestingly the two cases who demonstrated the greatest 
improvement in depression were also the most severely incapacitated by PD symptoms. 
When their two BDI factors were analysed, the findings indicated that most of the 
improvement could be attributed to a reduction in cognitive symptoms. These findings 
suggest the cognitive aspects of therapy might be effective on their own, although ffirther 
research would be need to confirm this view. 
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Some studies (Gotham, Brown & Marsden, 1986; Huber, Freidenberg, Paulson, 
Shuttleworth & Christy, 1989) but not others (Erdal, 2001) have noted a difference in the 
type of cognitive symptoms endorsed on the BDI by people with PD depression. In this 
case series, a disparity was often noted between what people said during therapy (i. e. 
three patients did not consider themselves worthless, guilty, or punished), and what was 
reported on the BDI. Nonetheless the observation that people with PD may not 
acknowledge psychological symptoms has implications for the cognitive model of 
depression which assumes that depressed people usually attribute their depressogenic 
experience to a defect within themselves (Beck, 1967; Wright & Beck, 1983). Likewise 
the concept of a cognitive triad (Beck et al., 1979) which presumes that depressed people 
also hold distorted views of ongoing experience and the future, does not appear to be a 
good fit with the PD depression experience. The reporting of negative public responses 
to observable PD symptoms (e. g. falling, tremor) or concerns about illness prognosis may 
represent rational appraisals of ongoing circumstances rather than cognitive distortions. 
Even though some aspects of the cognitive model do not seem to be fully 
congruous with PD experience of depression, the therapeutic work undertaken 
demonstrated that it was possible to utilise cognitive techniques to work with adverse 
situations (Wright, Thase, Beck & Ludgate, 1993; Moorey, 1996; Scholey & Woods, 
2003). Each patient had experienced previous critical incidents (e. g. death of relatives 
following degenerative illness) that had created negative ways of interpreting current 
experience (e. g. belief in inability to cope with ongoing health problems), which could 
replaced with less distressing alternatives. Whether the focus of reinterpreting thoughts 
is sufficient to alleviate depression in the PD population will need to be followed up in 
later studies because the data presented here imply it was not wholly effective for all. 
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The issue of whether PD depression is biologically mediated was not addressed 
directly by this study but deserves some comment in light of the opinion that 
psychological management may be ineffective for endogenous or organically based 
depression (Lieberman, 1998). Although there were indications that fluctuations in mood 
corresponded to changes in PD motor symptoms in at least two patients (Cases I and 5), 
it was not possible to determine the direction of the effect. Rather than allowing the 
biological versus reactive argument to dictate decisions on treatment, we believe the data 
from this study show that the emphasis on 'coping with' rather than curing depression 
taken in Beck (2000) can be applicable to all patients with PD depression irrespective of 
underlying cause. 
There were several limitations in the present design. Firstly, we are unsure 
whether the patients seen were typical of people with PD depression. All participants had 
not had any contact with PD organizations, because they did not want to know details 
about prognosis. Also we are aware that some of the problems known to be associated 
with PD depression, such as dementia, and depression following diagnosis of PD were 
not represented among those that received the brief intervention (Cubo Bernard, Leurgans 
& Raman, 2000; Brown, MacCarthy, Gothan, Der & Marsden, 1988). 
There was an attempt to control for methodological weaknesses by introducing 
distinct baseline leTigths to vary the timing of the intervention. Following careful 
deliberation concerning patient needs, it was felt that it would be ethically inappropriate 
to unduly delay treatment with vulnerable adults. Only one therapist was used to deliver 
all the interventions. It is not known whether the pattern of results reported here were 
attributable to individual therapist factors or the CBT intervention (Lambert & Okiishi, 
1997). However, given the scarcity of treatment literature for PD depression we think the 
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evidence for improvement constitutes adequate grounds for following up with a more 
rigorous research study. 
There have been few guidelines highlighting the type of changes to delivery that 
might be required for people with PD depression. In retrospect, given that the cases 
presented here were complex, it was felt that therapy of longer duration might have been 
more appropriate. Psychological issues were often closely tied to disease complications, 
which highlighted a need for a comprehensive understanding of the disorder, or to work 
in conjunction with other PD specialists to provide the best management for depression. 
The observation that some sessions needed to be terminated early as a consequence of 
switching off highlighted the need for flexibility. Finally it is easy to overlook the impact 
of cognitive deficits on therapy. Difficulties constructing alternatives to negative 
thoughts and poor recall of previous sessions may be a consequence of the 
neurodegenerative process. Strategies such as encouraging the therapist to supply 
examples of tolerable thoughts, using repetition, frequent summarising, and providing 
written material may improve treatment effectiveness. 
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Table 1. Treatment protocol for CBT following format outlined in Beck (2000) 
Session 1: Education and information on the structure of future sessions. 
Booklet heading - How do I know ifI am depressed 
Session 2-5: Behavioural work 
Booklet heading - How should I change my behaviour 
Cognitive work 
Booklet heading - How do I change my depressed thinking 
Session 6: Problems solving and barriers to compliance with medical advice 
Booklet heading - How do I solve my problems 
- How can I help myseýffollow my doctors advice 
Session 7: Review of previous sessions 
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Table 2. Issues raised during restrucLtLrlýn 
Cognitive restructuring 
Patient 1. Falling in public - embarrassment 
Consequences of falling at home alone 
Problem solving 
Preparing for major surgery. 
Preparing for falls at home. 
Patient 2 Unpredictable deterioration 
Being left alone to cope 
Patient 3. Believing one was too old/ill to 
try anything new or change 
Patient 4. Fear that PD symptoms would 
lead to another disease. 
Patient 5. Unpredictable deterioration 
Becoming a burden to the family 
How to cope with a friend 
dying with terminal illness 
How to manage PD symptoms 
Putting together questions 
to ask at next PD clinic appointment. 
How to cope with fluctuations in mood. 
How to ask family about being a burden. 
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Table 3. Demographic and caical findings for GDS. BDI-II. and PDQL 
Patient (jzender/aae) I(M/51) 2(E/72) W/83) 4M80) 5(F/82) 
Medication for mood 
Hoehn and Yahr stage 
No 
3 
Sinemet + 
2 
No 
4 
No 
2/3 
Mirtazapine 
3 
Previous history of 
Mental health problems No No - No Yes Yes 
GDS 
Pre 75 12 5 13 
Post 21738 
Follow up 11627 
BDI-II 
Pre 16 7 20 12 34 
Post 12 6 11 to 23 
Follow up 15 8 10 8 20 
PQLQ (total) 
Pre 118 158 95 132 86 
Post 119 149 91 137 102 
Follow up 119 149 94 130 98 
PQLQ higher score indicates a better perceived quality of life 
+ Sinemet is in antiparkinsonian drug which was used in this case to alleviate symptoms of l ow mood 
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The Feasibility of Using Brief Cognitive Behaviour Therapy 
for Depression Associated with Parkinson's Disease: 
Critical Appraisal 
Overview 
This study aimed to test the hypothesis that brief Cognitive Behaviour Therapy 
(CBT) would reduce symptoms of depression in people with Parkinson's disease (PD). 
To borrow a phrase used by Rokke, Tomhave, and Jocie (2000), the results are "positive 
but guarded" (p. 117). According to the BDI scores, two patients demonstrated a 
clinically meaningful improvement in mood during the intervention, which apart from 
neurodegenerative factors, did not -appear to be accounted for by other extraneous 
variables. In the critical review to follow, methodological issues relevant to the 
interpretation of findings will be discussed before examining the contribution the study 
has made to theoretical and clinical understanding. 
Methodological issues 
The implications of change from grouj2 design to a single case senes. 
A repeated measures group study was designed initially to test the prediction that 
CBT would lead to a reduction in symptoms of depression. Success would have been 
evaluated by comparing the within subject differences between pre, post and follow up 
measures. Tests for statistical significance would have been applied to control for the 
possibility that any differences had not occurred by chance. Although practical 
difficulties meant that it was not possible to include a between group comparison (e. g. 
waiting list control), the methodology would have permitted conclusions to be drawn 
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about CBT effectiveness for an average group of people with PD depression. Just before 
data collection was to start, it was necessary to change the design because most 
individuals already identified in patient records with depression had been included in a 
drug trial which would have compromised their participation in this study. In 
consequence participants had to be identified prospectively, which made it impossible to 
complete the study as planned within the time available. Even though only half of the 
fourteen participants recommended by the power analysis calculation participated in the 
research (five participants and two were not suitable), it is interesting to note that other 
researchers have mentioned a comparable inability to collect data as anticipated when 
faced with similar time constraints (e. g. Myles, 2002, anticipated participants n=9, 
sample participants n= 2). 
As an alternative, the investigator used a single case series. In contrast to group 
studies, the single case approach has more clinical utility because it provides information 
on whether for an individual with a particular set of illness circumstances, an intervention 
is more/less likely to facilitate recovery. Similarly Hayes, Barlow, and Nelson-Gray 
(1999) maintain that single case methods are a useful first step in establishing the efficacy 
of new treatment programs. If it had been possible for the investigator to select the 
sample, participants would have been matched for specific factors such as disease type, 
severity of depression or content of depressed thought (e. g. worry about falling). The 
intervention started at different points in real time, which controlled for external threats to 
validity, such as world events. To control for threats to internal validity (Kazdin, 1981), 
participants were put on a five or ten day baseline 
_in 
an attempt to ensure that any 
improvement occurring dufing the intervention phase could not be attributed to the length 
A 
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of time that patients had been in the study. From an ethical perspective it would have 
been inappropriate to impose longer baseline phases, or withhold supportive 
psychotherapy during pre-intervention visits if the patient was in distress. Also it was 
considered unlikely to be possible to achieve a stable baseline before intervention if PD 
depression is connected to fluctuations in the disease process. 
In spite of design weakness, suggestions for establishing treatment efficacy were 
applied (Chambless et al., 1996; Roth & Fonagy, 1996). A 'probably efficacious 
treatment' can include single case experiments (n = 3) provided that the intervention uses 
treatment manuals, and the characteristics of clients are clearly specified. The study was 
set up to incorporate the information that would facilitate replication, including a detailed 
description of, a) patients b) procedure, c) intervention conditions, and d) measures 
(Hayes et al., 1999). Finally potential moderators of treatment effects were identified, 
including comorbid anxiety, pessimism and cognitive dysftmction (Kazdin, 2001). 
Although the results according to the BDI data are not sufficiently strong to establish 
CBT as a 'probably efficacious' treatment at this stage, it was possible to distinguish 
selection criteria for a future replication. 
A representative sample 
The heterogeneity of PD population cannot be overstated (Kaiser, Bodey & 
Bodey, 2000). Participants varied in disease type, duration and severity of depression. 
One characteristic that might set this participant group apart from other people with PD 
relates to their individual decisions not to access information about the disorder or be 
involved in support groups. A link between avoidant coping and depression has been 
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established previously (Finset & Andersson, 2000), and it is known that not all people 
with PD adopt this style (Sanders-Dewey, Mullins, & Chaney, 2001). 
Results from two patients were not commented upon in detail in the research 
paper. One patient who described his affect as 'depression on top of depression' was 
experiencing deluded thought as a side effect of anti-parkinsonian medication. The 
intervention, which was based on literature looking at CBT for psychosis (Kingdom, 
1998) was difficult to apply because the patient would only engage in therapy during 
lucid moments. The outcome was positive in the sense that he was visibly more at ease 
with the symptoms during the final therapy visit. The second patient was in the advanced 
stages of PD. She was experiencing suicidal ideation but was unable to concentrate on 
CBT due to the severity of her PD symptoms. It was necessary to attend to the patient's 
capacity to cope with another hour/day, before arranging respite support. Literature 
would suggest that these complications do occur in depression related to PD, but clearly 
require an individually tailored rather than a brief protocol driven intervention. 
The validily of materials used 
Questionnaire measures. A discussion regarding the validity of GDS and BDI 
appeared in the paper and therefore will not be repeated here. The fact that the measures 
were not consistent in screening for depression illustrates the need to identify scales 
which effectively discriminate between depressive, cognitive and somatic symptoms in 
PD. 
Repeated self-rating measures. Repeated measurement is the hallmark of the 
single case design. Just as there are problems with interpretation when using 
questionnaires, so to there are difficulties associated with self-monitoring (see Barlow, 
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Hayes, & Nelson 1984 for limitations of repeated measurement). In retrospect, the 
investigator felt that direct observation may have provided a more precise method of 
measuring change, because cognitive dysfunction and individual factors (e. g. pessimism 
regarding therapy outcome; Safran & Segal, 1996) appeared to influence the accuracy of 
some client reports. In case three, the reduction in depressive symptoms demonstrated by 
the questionnaire data was not matched by a decline of low mood as measured by the 
patient's self-monitoring (see Figure 1 research paper). At the start of each session the 
client would preface her mood rating with comments like, 'what can you do to help me 
when it is the PD that has caused this' and then provide a rating similar to other sessions. 
As the intervention progressed she began to smile more frequently and it was evident that 
her mood had lifted. A record of smiling would have been a more reliable indicator of 
progress, but it would have been impossible to appreciate the relevance of this behaviour 
at the outset. Alternatively, other methods of gathering data could be considered, such as 
using carer reports or asking people to provide verbal rather than written records. 
Although the self-report measures used may present some validity problems, they have a 
precedent for use in research (Tiplady, Jackson, Maskery & Swift, 1998; Harmon, Nelson 
& Hayes, 1980; Dick et al., 1995), and the results have given an indication of how to 
adapt measures in future studies. 
The self-helj2 booklet. The use of structured self-help materials for CBT is 
becoming more common (Keeley, Williams & Shapiro, 2002), and have been advocated 
as one of the requirements for establishing empirically supported treatments 
(Chamberless & Ollendick, 2001). The manualised approach is felt to be a way of 
ensuring therapy is delivered in a uniform and replicable manner, although some findings 
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suggest therapist variation can be substantial (Malik, Beutler, Alimohamed, Gallagher- 
Thompson & Thompson, 2003; Najavits & Strupp, 1994; Lambert & Okiishi, 1997). 
The use of a treatment protocol is legitimate if the contents of a programme 
address the issues arising for the targeted group. ViMle Beck (2000) provided a clear 
articulation of cognitive therapy and clients found it easy to follow, there were 
indications that the booklet was inadequate in several respects. Two patients did not like 
to use the word 'depression', a finding which is consistent with literature showing many 
older adults prefer not to admit to being depressed (Friedhoff, 1994). A more serious 
limitation relates to the absence of background information on the physical aspects of PD 
and their potential relationship with depression. The failure to cover the complexity of 
symptoms experienced on a daily basis by people with PD was seen to be an 
oversimplification by some and offensive by others. 
Therapist adherence to CBT as outlined in the Booklet 
Determining whether the therapist adhered to cognitive therapy as outlined in 
Beck (2000) is important, because it was not possible to enlist an independent assessor to 
observe delivery. Analogously the therapist believed the use of tape-recording would 
impose an extra burden on frail adults who already appeared to find the process of 
reading the information sheet and signing consent forms daunting. Even if adherence to 
protocol had been evaluated, Jacobson and Gortner's (2000) reported disagreement 
between recognised master experts in cognitive therapy ratings for therapeutic 
competency suggests external ratings are not a fool proof method of establishing 
treatment integrity. 
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The case overviews outlined in the paper demonstrate adherence to the structure 
of Beck (2000) but also considerable flexibility in how it was applied. Given that the 
booklet is designed as self-help material, no provision was made for formulating the 
problem. As all cases were complex, it was essential to have a comprehensive 
understanding of how symptoms were uniquely presenting for each individual, before 
starting the intervention. The delivery of therapy called for a greater degree of 
sophistication than was implied by the booklet. Participants appeared unable to identify 
thoughts without the assistance of supplementary Socratic questioning techniques. Also 
the therapist had to facilitate the process of identifying reasonable alternative thoughts to 
a greater extent than was anticipated. Additionally, the physical problems associated 
with psychological difficulties often needed to be addressed. For example, in the 'fear of 
falling' case, cognitive restructuring was covered in the context of an understanding of 
how and when motor freezing was likely to occur and the practical strategies that could 
be applied to overcome the block. The experience of using the booklet has shown that, 
in practice, rigid adherence to a set format could be invalidating for the client unless the 
clinician has the scope for adapting the underlying cognitive principles to fit the needs of 
patients. 
Contribution to theoretical and clinical understanding. 
The major strength of this study has been its capacity to inform clinicians about 
how CBT may need to be adapted to address the complex presenting problems of people 
with PD depression. Findings from general depression research, that not all people 
benefit from CBT (King, 1998; Shea et al., 1992), show that the mixed results reported in 
this study are not exclusive to PD. On the other hand, reflecting on the cases where CBT 
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did not seem to work as well has provided insight into the potential barriers to successful 
outcomes particular for this client group including (a) the deficiency of Beck's theoretical 
model when applied to rational thoughts, and, (b) the relevance of biological mediators. 
Rational cognitions. Despite refinements to Beck's cognitive model of 
psychopathology over the years, the key focus on disordered thinking has remained 
unchanged with the stated aim of therapy being to demonstrate "that a particular belief is 
wrong or dysfunctional and that another belief is more accurate and adaptive" (Beck, 
1996: p. 15). When thoughts are both accurate and maladaptive in the sense that a 
rational appraisal creates emotional discomfort, the application of the cognitive approach 
becomes more complicated (Moorey, 1996). The process of therapy was able to uncover 
unhelpful assumptions (e. g. 'if I deteriorate then I will become a burden to my family'), 
that could be explored and replaced by more enabling alternatives. Within sessions, 
clients stated that they found the approach helpful, yet on occasion their symptoms of 
depression showed little change. This finding might suggest that tackling -underlying 
assumptions may have limited clinical utility when the core fears like falling and 
deterioration are real. For example, the client who found the evidence that her family did 
not perceive her to be a burden comforting stated, 'but I still do not want my family to be 
cresponsible' for me. Perhaps then, what many depressed people with PD are struggling 
with is not distress associated with distorted thinking but the discomfort that arises from 
being in a situation that is understandably difficult to accept. 
Health psychology models such as the self-regulatory theory (Leventhal, Mayer, 
& Merenz, 1980) have highlighted the critical role of cognitive factors in adjustment to 
chronic illness. In the context of discussing theories of health and illness perception, 
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Petrie and Weinman (1997) argue that CBT may be an appropriate intervention when the 
aim of therapy is to "get people to think differently about their illness" (p. 15). While 
Beek's cognitive theory of depression, focuses primarily on the implications of distorted 
thinking to inform practice (Beck, 1996; Clark, Beck & Alford, 1999), other clinicians 
have applied therapeutic strategies arising from the model to alleviate the distress 
associated with poor adjustment to illness. For example Bates, Bums and Moorey (1989) 
maintain that encouraging a realistic (e. g. 'people with PD do fall') but positive 
perspective (e. g. 'here is the evidence that you can cope if you fff) will enable the 
medically ill individual to, "accept their disability with a greater sense of inner peace" (p. 
273). As this study has shown, when beliefs concerning an illness are plausible it could 
be invalidating for the client to challenge them. However if the accent of therapy is 
placed on the implications that the meaning of an illness holds for overall adjustment, it 
may not matter whether thoughts are distorted or correct, the objective would be to use 
the tools of cognitive therapy to explore the extent to which the appraisals are damaging 
for well being. Clearly when the barriers to acceptance are explored from this broader 
perspective, the content of therapy sessions may cover issues other than the irrationality 
of cognitions. 
Biologically mediated depression. The belief that PD depression is biologically 
mediated is widely held and was commented upon by Craig White, author of the book 
'Cognitive Behaviour Therapy for Chronic Medical Problems', as a potential explanation 
for the present results (White, 2003, personal communication). If the affective 
experience, as opposed to the cognitive interpretation of that affect, has its roots in the 
neurochemistry of PD, CBT may not be sufficient on its own to promote full recovery. 
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There was evidence to indicate that organic variables had adversely affected outcomes 
(e. g. switching off within sessions; impaired memory), though it was not possible to 
establish whether these symptoms were specific to PD or a feature 'of PD depression 
(Serra-Mestres & Ring, 2002). Until we have more information on the nature of PD 
depression, we can only sunnise that therapists would be advised to acknowledge the 
potential organic basis of depression. with clients. 
In the mean time, observing the potential impact of disease processes on therapý 
advises us to consider what the implications would be for future research of this nature. 
In the first section of the thesis, adaptations to the mode of delivery were suggested 
which included, slowing the pace of delivery, providing examples of abstract thinking, 
and using memory aids (Crews & Harrison, 1995). An awareness of these strategies was 
worthwhile, but the inclusion of a neuropsychological assessment might have led to more 
proficiency in delivery by highlighting particular areas of impainnent before intervention. 
Given that the impact of motor fluctuations and associated physiological responses was 
greater than anticipated, it could be helpful to ask people to provide a detailed record of 
symptom changes over a typical day, including their responses to medication. 
Conclusion 
There is an immense gap in the literature guiding service providers in how to 
manage depression associated with PD. This study has evaluated whether CBT holds 
promise as a treatment option. The findings infer that CBT may reduce symptoms of 
depression in certain people with PD, but more empirical validation is required before it 
is recommended as a routine feature of clinical practice. To carry the research forward 
there is an urgent need for information on how the neurological aspects of PD (e. g. the 
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'on-off phenomena; cognitive difficulties) affect treatment responsivity. Equally we 
need to establish whether adaptations to overcome the organically mediated impediments 
actually help, perhaps by comparing a standard CBT delivery to modified delivery. If 
future studies verify the difficulty in using behavioural, strategies with chronically ill 
patients, it would be important for Beck's theory to establish the relative extent to which 
non-specific factors and cognitive techniques contribute to successful outcomes. Finally, 
thinking about actual practice, it is clear that therapy with PD patients presents a 
considerable challenge. Clinicians considering work in this area require the competence 
to apply CBT creatively along with the vigilance to be aware of when organically 
mediated changes may be hindering progress. 
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INFORMATION SBEET 
The effectiveness of Brief Cognitive Behaviour Therapy In reducing the 
symptoms of depression In individuals with Parkinson's disease. 
You are being asked to take part in the *above study. The study has been 
reviewed by the North Wales Health Authority Research Ethics Committee, 
and the University of Wales Ethics Committee, Bangor. Before you decide 
it is important for you to understand why the research is being done and 
what it will involve. Please take time to read the following information 
carefully and discuss it vVith friends, relatives and your GP if you wish. Ask 
your psychologist when she call's, if there is anything that is not clear or if 
you 
' 
would like more information. Take time to decide whether you would 
be willing to take part. 
What the research Is about 
Long-term illnesses are sometimes difficult to come'to terms with. We are 
interested in helping people cope with feeling low when they have 
Parkinson's disease. The aim of the study is to see if a'type of therapy 
which has been shown to help people suffering with various illnesses such 
as-long-term pain, can, also help people who get depressed with 
Parkinson's disease. 
Why have I been chosen? 
You have been chosen because one of the forms you filled in while 
attending at the Parkinso 
, 
n's Disease Clinic suggested that there might be 
times when you feel low. We will be asking 20 people who attend the 
Parkinson's Clinic to take part in the study. 
Do I have to take -part? 
It is up to you to de 
, 
cide wheth6r or not to take part. If you do decide to 
take part you will be given this information sheet to keep a'nd be asked to 
sign a consent form. You are able to withdraw form the therapy at any 
time without giving a reason'. If you do withdraw it Will not affect the care 
you are receiving through the Parkinson's disease clinic. 
'I 
hdited by the 
011h Quality Service 
Erskine House, 74 Conwy Road. Colwyn Ray, LL29 7LD. 
Tel: 01492 531332 Fax: 01492 535433 
CIO,: ý I NH4 T, 70? OF CYMR 
WALE 
What will happen to me If I take part? & 
I (Kristina Cole) Will visit you at your home for one hour per week for seven 
weeks, and then once, a month later to see how you have been getting 
on. To see if the therapy has helped, you will be asked to fill in three 
questionnaires three times, 1) on the first visit, 2) on the last therapy visit 
and 3) on the visit a month later. It is OK to allow relatives or friends help 
you to fill out the forms. 
It would also be helpful to know how you have been doing each week. 
You may be asked to mention a couple of things (e. g. how low or tired 
you have been or what things Parkinson's disease has stopped you doing) 
in the two weeks before, during and after therapy. 
What type of therapy Is It? 
You will be given a booklet to keep called 
Coping with Depression When You Have Parkinson's disease 
The booklet includes the following sections 
How do I know if I am depressed? 
What can I do? 
How should I change my behaviour? 
How do I change -my depressed thinking? 
- How do I solve my problems? 
The psychologist Will work with you to try out various ideas mentioned in 
the booklet. These ideas have been show to help people With various 
illnesses. 
Are there any alternative treatments for feeling low? 
Sometimes people who have been feeling low will be prescribed 
antidepressant medication by their GP or by the Doctors working at the 
Parkinson's Clinic. You can still participate in the research if you are taking 
any form of medication. 
Are there any disadvantages to taking part? 
A lot of people think that therapy can take all their problems away. This is 
not possible when living with a long-term illness. The aim of therapy is to 
provide people with ways of managing and coping with feeling 
depressed. 
What are the benefits of taking part? 
We hope that the therapy will help. However, as this therapy has not 
been ffled with Parkinson Disease, this cannot be guaranteed. The 
information we get from the study will help us know what type of 
treatments help patients with Parkinson's disease. 
What happens when the therapy ends? 
This therapy is only a short course to help you to cope With your 
depression. At the end of therapy various options may be discussed with 
you. 
Who will know about the results? 
All information will be treated as strictly confidential and will be kept in a 
locked filing cabinet at all times. If you agree to take par 
' 
t, you will be 
asked to sign a consent form, which will be kept in your clinical file. We will 
let your GP know in a letter what is happening, and send a copy of this 
information sheet. A report of the results for the whole group will be 
written by the psychologist and sent to you in the post during the summer. 
Who Is organizing and funding the research? 
Dr Kristina Cole is organiAng and conducting the research as part of her 
training for a Doctorate in Clinical Psychology based at the North Wales 
Clinical Psychology Course, University of Wales, 43 College Road, Bangor, 
LL57 2DG. (Contact no 01248 386235). No payment will be made for 
taking part in the study. 
What will happen next? 
1) Read through this information sheet carefully and talk it oyer with 
others if you Wish. 
2) 1 will return at a convenient time. If you have any further questions 
feel free to ask. 
3) If you agree to take part, you will be asked to read tlýe consent 
form and sign it. Arrangements Will be made for the home therapy 
visits. 
4) If you prefer not to take part, the care you receive through the 
Parkinson's Clinic will not be affected in any way. 
If you would like any further information do not hesitate to contact me 
Dr Kdstina Cole 
Tel. 
THANK YOU FOR READING THIS INFORMATION SHEET 
--k 
A 
6 
YmcIdIrledolaeth GIG SIroedd Conwy a Dinbych 
Conwy & Denbighshlre NHS Trust 
'rim Gogledd Cymru I Bob[ Sydd Wedi Cael Anar I'r Ymennydd 
Ff6n: 01492807766/807521 Ffacs: 01492516S87 
CONSENT FORM North Wales Team for People with an Acquired Brain Injury 
Tel: 01492 807766/807521 Fax: 01492SM87 
Title of Project , 
The effectiveness of Brief Cognitive Behaviour Therapy in reducing the 
. symptoms of depression in individuals with Parkinson's disease. 
-Name of researcher 
Dr Kristina Cole (under the supervision of Dr Frances Vaughan) 
Please delete as appropflate 
1.1 confirm that I have read and understand the information 
sheet for the above study and have had the opportunity 
to ask questions Yes I No 
2.1 Understand that my participation is voluntary and 
that I am fee to withdraw at ay time, without giving 
any reason, without my medical care or legal rights 
being affected. Yes I No 
31 understand my GP will be informed that I am taking 
part in this study, and I have seen a copy of this letter. Yes I No 
4.1 agree to take part in the above study. Yes / No 
Name of Patient Date Signature 
Name of person taking consent Date 
(if different from the researcher) 
Name of person taking consent Date 
ý. Cyrnunecl Bae Colwyn. Ffordd Hesketh, Bae Colvvyn, Conwy LL29 8Ay 
, 51492 SI S218 Ffacs: 0 1492 S 18103 
jý Bay Community Hospital, Hesketh Road, CoNvyn Bay. Conwy LL29 BAY 
h1492515218 Fax: 01492518103 
Signature 
Signature 
NHS ý& 
CYMRU 
YmcIdIrledolaeth GIG Slroedd Conwy a Dinbych 
Conwy & Denblghshlre NHS Trust 
The effectiveness of Brief Cognitive Behaviour Therapy in reducing the symptoms 
of low mood and depression in individuals with Parkinson's disease. 
Dear Dr 
Re 
I am writing to inform you that your patient has agreed to participate in the above 
research study, and a, consent form has been signed. This study received ethical approval 
from the North West Wales Health Authority Research Committee. 
The study. aims to evaluate whether brief cognitive behaviour therapy (CBT) can help 
patients with ParkinsoWs disease who are experiencing symptoms of depression. CBT 
has- *n . derponstrated to--be an-effective psychological-therapy for, individuals- coping 
-. 1--mith. arange, of medicalconditions. including- palliativeý care -and chronic pain-: ýHowwe'ver-,, it"s efficacy with Parkinson's disease has not been established. 
Please find enclosed the information sheet passed onto -your -patientj which outlines -the- 
main components of therapy. Participation will not interfere in any way with treatment 
as usual, received through your practice or the Parkinson's disease clinic. If you would 
like any more information, or if you have any questions about the study, please do not 
hesitate to contact me. 
Yours sincerely 
Dr Kristim Cole 
Trainee Clinical Psychologist 
Contact telephone number before 
After 
Dr Frances Vaughan 
Clinical Psychologist. 
October 1,2002 01492 531332 
October 1,2002 01492 807773 
Ymddirledolaeth GIG Slroedd Conwy a DInbych 
Conwy & Denbighshire NHS Trust 
The effectiveness of Brief Cognitive Behaviour Therapy in reducing the symptoms 
of low mood and depression in individuals with Parkinson's disease. 
Dear 
Staff working at the Parkinson's disease clinic may have mentioned a research -, study 
which is aiming to use brief therapy tohelp people cope with feeling down in Parkinsorfs 
Disease. You are being asked if you would like to take part in the study. 
I would like to offer you an initial home visit on ................................................ 
The aim of the visit would be to explain a bit about my self, what the therapy involves 
and to give you the opportunity to ask questions. If you would prefer me not to call, or 
the above time or date is not convenient please do not hesitate to contact me (Kristina 
Cole) on the number below. If you decide not to take part in the study the care you 
receive through the Parkinsons disease clinic will not be affected in any way. 
Yours sincerely 
Dr Kristina Cole Dr Frances Vaughan 
Trainee Clinical Psychologist Clinical Psychologist 
Contact telephone number before October 1,2002 01492 531332 
Afler October 1,2002 01492 807773 
V Supplementary case material 
I Summga of CBT sessions per client 
Summary of CBT sessions per client 
Case One 
Session I How do I know i(I am depressed 
Client denied feeling suicidal, worthless, or guilty but stated he was finding it difficult to come to terms 
with giving up work. 
Session 2-3 How should I change my behaviour 
Client stated he was already keeping as active as possible to manage feeling low. He attended football 
matches despite being unsteady on his legs, had taken up a new hobby (collecting for car boot sales) since 
leaving work, and had taken over household duties such as shopping and cooking. 
Session 4-6 How do I change my depressed thinking 
The client revealed that fear of falling was the main concern he had with regard to PD symptoms and that it 
was becoming more difficult to go out in public as his symptoms worsened. 
SummM formulation 
Life experiences 
Falling as a child and being cut by broken glass. 
Local man found dead at home following a fall. 
PreciPitating'factors 
Freezing and stumbling when trying to get through the doorway at home. 
Freezing and stumbling when approaching confined spaces in public. 
Automatic thoughts 
If I fall at home no one will be there to help and I will die. 
People will see me and think I am drunk -I will be embarrassed. 
Reasonableness of thought (cognitive challenging) 
Evidence for falling in PD (literature) 
Reviewing consequences of falling 
Reviewing coping following a fall 
Strategies to limit the possibility of falling. 
Session 7 How do I solve my problems 
Preparing questions to ask prior to surgery. 
Looking into strategies to get through doorways when freezing occurs 
Parkinson's symptoms with the potential to influence therapy 
Switching off during therapy (e. g. sweating, poor concentration, exacerbation of movement difficulties). 
Poor recall of work done during therapy revealed at the follow-up session 
Case two 
Session I How do I know i(I am depressed 
Client denied feeling suicidal, or guilty and that she was very reluctant to use the word 'depressed', but 
consented to use the word 'low'. She stated that it is 'ingrained' in the older generation to present as if one 
is coping well and not to admit to feeling low. 
Session 2-3 How should I change my behaviour 
Client had a supportive husband and together they kept up an active social life. She was finding it 
increasingly more difficult to keep up with usual activities as she tired more easily, and was very anxious 
that people would notice the observable tremor. She was encouraged to include more pleasant activities 
particularly in the morning when the internal tremor started. 
Session 4-6 How do I change my depressed thinking 
This client was concerned about the prognosis because she had cared for two relatives who had 
degenerative conditions and did not want her husband to go through the same experience. 
Summgy formulation 
Life experiences 
Caring for sick relatives at the home until they died. 
One family member had a degenerative illness. 
Precipitating factors 
The onset of the internal tremor every morning. 
Automatic thoughts 
Where is it going to end? 
Reasonableness of thought (cognitive challenging) 
Evidence for prognosis in PD 
Evidence of capacity to cope should the worst happen 
Evidence that she would be a 'burden' 
Sesson Mow do I solve my problems 
Reviewing how to cope when visiting a friend who was dying. 
Parkinson's symptoms with the potential to influence therapy 
No symptoms appeared to hinder the process of therapy. 
Poor recall of work done during therapy revealed at the follow-up session 
Case Three 
Session I How do I know ifI am depressed 
Client took great offence to the cognitive symptoms mentioned in the booklet stating "what have I got to be 
guilty abouf'. She did acknowledge she was depressed and was happy to use the word when describing her 
symptoms. 
Session 2-3 How should I change my behaviour 
Client followed the same routine every day. Her husband brought breakfast in bed and she read the 
newspaper until dinnertime. After dinner she sat on her settee and did not engage in any activity until 
teatime. Even though she said the afternoon was the time she felt most low, she was resistant to the idea of 
introducing pleasurable activities 'you do not play cards when you are 82', but finally agreed to plan email 
messages to her daughter. 
Session 4-6 How do I change my depressed thinking 
This client felt nothing could be done to change the fact that she was old and had PD and believed that if 
she did not have PD her mood would be fine. Her mood seemed to lighten (e. g. increase of smiling) as we 
explored how other people with PD might be managing their mood. 
SummM formulation 
Life experiences 
One sibling had emigrated to Australia 
Precipitating factors 
Felt low most of the time but an exacerbation occurred when PD were 
were worse (e. g. headaches, backache, poor sleep, bladder problems) 
Automatic thoughts 
What is the point in anything anymore -I am old 
You can't do anything to change things. 
Reasonableness of thought (cognitive challenging) 
Evaluated how other adults with PD might perceive their situation 
Sesson Mow do I solve my problems 
Reviewed methods of keeping in contact with family. 
Planned what issues she needed to raise with regard to surgery at the next clinic appointment. 
Parkinson's symptoms with the potential to inj7uence therapy 
This lady had multiple health problems and experienced frequent headaches following sleep disturbances. 
Sessions were shortened when her psychical symptoms were severe. Possible executive deficits 
contributing to difficulty in abstract reasoning. 
Case Four 
Session I How do I know ifI am depressed 
This client acknowledged he was depressed but did not endorse the cognitive symptoms of 
worthlessness and guilt. He described his symptoms as a black cloud coming over every day. 
Session 2-3 How should I change my behaviour 
This client had become preoccupied with one of the complications of Parkinson's disease and would not 
engage in any activity because of the problem. 'He was encouraged to follow his usual routine in spite of 
his worries, and increase pleasurable activities but he was difficult to motivate. 
Session 4-6 How do I change my depressed thinking 
He readily acknowledged that his concerns were psychological rather than physical, but he did not seem to 
be able to process information on alternative thoughts easily. 
SummM formulation 
Life experiences 
Mother died of terminal illness 
Precipitating factors 
PD diagnosis and literature on a health complication 
Automatic thoughts 
If X happens, I will get cancer and I will die in hospital 
Reasonableness of thought (cognitive challenging) 
Evidence for complication in PD 
Evidence for complication outcomes in general population 
Evidence of capacity to cope in hospital situations 
Sesson 7 How do I solve my problems 
Planning what questions to raise at the next clinic appointment. 
Planning to discuss health issues with long standing friend. 
Parkinson's symptoms with thepotential to influence therapy 
There may have been evidence of slowness of processing information because he appeared to find it 
difficult to reflect on what was being said. 
Case Five 
Session I How do I know ifI am depressed 
Client readily acknowledged all symptoms mentioned in the booklet and was happy to use the term 
depression. She believed mood variations corresponded with the fluctuation of PD symptoms. 
Session 2-3 How should I change my behaviour 
Although a previously sociable individual, the depressed mood had resulted in a reluctance to go out of the 
home. During activity planning, she was encouraged to attend a group for older adults with mental health 
difficulties for one day a week, and invite the neighbours in for a coffee one afternoon a week. 
Session 4-6 How do I change my depressed thinking 
Like case 2, having cared for sick relatives, this client was in fear of becoming a 'burden' to her husband 
and family. 
Summaly formulation 
Life experiences 
Previous MH history following the suicide of relative 
Caring for mother with physical problems for 30 years. 
Precipitating factors 
Fluctuations in PD symptoms 
Automatic thoughts 
PD is a punishment for not preventing suicide 
If I get worse I will become a burden to my family 
Reasonableness of thought (cognitive challenging) 
Issues surrounding suicide and onset of PD 
Evidence that she would be a 'burden' 
Sesson 7How do I solve my problems 
Planning how she could manage low mood on a daily basis. Discuss the advantages and disadvantages of 
discussion feelings connected to suicide with family members. Arrange continuing psychological support. 
Parkinson's symptoms with the potential to influence therapy 
Switching off during therapy (e. g. poor concentration, poor recall and exacerbation of movement 
diffliculties). 
VI Statement of word count 
Word Count 
1 Abstract 150 
2 Ethics proposal and research protocol 2250 
(not including text, references or materials) 
3 Literature Review 
(not including references) 6520 
4 Research Paper 
(not including table, figures or references) 5592 
5 Critical review 2918 
(not including references) 
Total 17,430 
Appendices 
1 Tables, figures and references 
Ethics proposal 406 
Literature review 3233 
Research paper 2444 
Critical review 878 
2 Measures and materials 1505 
3 Information sheet, consent, and letters of introduction 1573 
4 Supplementary case material 1440 
Total 11479 
VII Statistical information 
Formula used for the calculation of the Reliable Change Index 
RC= X2 -. Xl 
Sdif 
Figures required for the formula 
1 Geriatric Depression Scale 
SD = 3.1 Test re-test reliability 0.85 Sdif = 1.69 
2 Beck Depression Inventory - Total Score 
SD = 11.74 Test re-test reliability 0.93 Sdif = 4.39 
3 Beck Depression Inventory - Cognitive factor 
SD = 4.95 Test re-test reliability 0.85* Sdif = 2.71 
4 Beck Depression Inventory - Affective Somatic Factor 
SD = 8.0 Test re-test reliability 0.85* Sdif = 4.36 
As Steer, Ball, Ranier & Beck, (1999) did not cite test retest reliability scores for 
separate BDI sub-scales the conservative estimate of 0.85 was used. 
